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Klinefelter Syndrome (KS) is a genetic condition that occurs only in males. In 
adult men, KS is associated with reproductive, cardiometabolic, bone and psychosocial 
health problems that are believed to emerge during peri-puberty.  In children, the 
condition is under-diagnosed and not well understood due to the wide-ranging spectrum 
of physical features.  Although pediatric studies are rare, androgen deficiency is believed 
to underlie many of the KS-related abnormalities in both physical and emotional well-
being. 
The purpose of this dissertation was to systematically describe the physical and 
psychosocial health of peri-pubertal boys with KS. Aim I of the study was to explore 
associations between physical and psychosocial health while Aim II explored body 
composition and bone mineral density. 
For Aim I, a cross-sectional exploratory study examining the associations 
between physical phenotype, reproductive hormones, cardiometabolic risk factors, and 
psychosocial health was conducted in a sample of 43 boys with KS between the ages of 8 
and 18 years. Physical examination, laboratory and self-administered psychosocial health 
data were analyzed using descriptive statistics and univariate and multivariate linear 
regression techniques. For Aim II, a retrospective chart review examining body 
composition and bone mineral density (BMD) was conducted of 20 KS patients ages 8-18 






The implications from this study include recommendations that primary care 
providers and developmental specialists become more familiar with the clinical pattern of 
KS as represented by physical, hormonal as well as behavioral signs and symptoms. In 
primary care, it is recommended that complete genital examination including testicular 
volume measurement be conducted during well-child visits and that karyotype be ordered 
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 This study is dedicated to all boys, men and families affected by 47, XXY. Thank 
you to the participants of this study for the privilege of allowing me to come into your 
family and to examine your sons.  I appreciate your trust, your cooperation and the many 







Klinefelter Syndrome (KS) is a genetic condition in males characterized by the 
abnormal karyotype 47 XXY. The original cohort of KS patients, first described by Dr. 
Harry F. Klinefelter almost 70 years ago, included nine adult males with small testes, 
eunuchoid body proportion, lack of facial and body hair, gynecomastia and elevated 
concentrations of follicle stimulating hormone (FSH) (Klinefelter, 1986; Klinefelter, 
Reifensten, & Albright, 1942). Of affected individuals, approximately 80% have the non-
mosaic numeric chromosome aneuploidy while the rest are mosaic (47 XXY/46XY), 
have higher grade chromosome aneuploidies (48 XXXY, 48 XXYY, 49 XXXXY) or 
structural abnormalities in the X chromosomes (Lanfranco, Kamischke, Zitzmann, & 
Nieschlag, 2004; Kamischke, Baumgardt, Horst, & Nieschlag, 2003).   The hallmark 
feature of KS is progressive testicular failure that begins during adolescence (Bojesen & 
Gravholt, 2007; Smyth & Bremner, 1998). The supernumerary X chromosome is 
responsible for progressive destruction of Leydig cells in the testes and hyalinization of 
the seminiferous tubules (Wikstrom & Dunkel, 2008).  As puberty advances, the 
progressive destruction of testicular tissue creates androgen deficiency, which is thought 
to contribute substantially to many of the features of KS (Bojesen & Gravholt, 2007; 
Smyth & Bremner, 1998). 
 
Incidence   
 The incidence of KS is estimated to be approximately 1 in 500 to 1 in 1,000 male 
births (Lanfranco, Kamischke, Zitzmann, & Nieschlag, 2004). Live birth prevalence 
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statistics suggest that sex chromosome trisomies (SCT) including 47 XXY, 47 XYY and 
47 XXX have approximately the same prevalence of 1 in 1000 (Hook & Hamerton, 
1977). Morris and colleagues examined former birth prevalence surveys of sex 
chromosome trisomies including additional cytogenic studies of newborns, spontaneous 
abortions, perinatal deaths and prenatal diagnoses. Taking additional prenatal cytogenic 
studies into account, 47 XXY appears to have a greater prevalence compared to the other 
sex chromosome abnormalities (Morris, Alberman, Scott, & Jacobs, 2008).   
 
 Genetic Mechanisms in KS 
 The supernumerary X in the KS karyotype can occur due to non-disjunction 
during meiotic division of the parental germ cells or during mitotic cell division in 
embryogenesis (Abramsky & Chapple, 1997; Lanfranco, et al., 2004).  The extra X is 
reported to derive in equal proportions from maternal and paternal origins (Thomas & 
Hassold, 2003). Maternally-derived XXY may be due to errors during Meiosis I, Meiosis 
II, or during early mitotic division in the zygote with Meiosis I errors reported to be the 
most common (Lanfranco, et al., 2004).  Paternally derived XXY is due to errors during 
Meiosis I.  Sex chromosome errors during Meiosis II may only result in 47 XXX or 47 
XXY (Thomas & Hassold, 2003).  There has been evidence to suggest that sex 
chromosome aneuploidy is associated with advanced parental age (Harvey, Jacobs, 
Hassold, & Pettay, 1990), but these findings are disputed  (Eskenazi, et al., 2002; Herlihy 
& Halliday, 2008; Lowe, et al., 2001). Apart from the original description of the KS 
phenotype in 1942 and the 1959 discovery of the karyotype (P. Jacobs & Strong, 1959), 
the molecular mechanisms for KS remain poorly understood (Lanfranco, et al., 2004).  
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Statement of the Problem 
 While KS is the most common sex chromosome abnormality, it is thought to be 
grossly under-diagnosed.  It has been estimated that only 25% of men with KS ever 
receive a diagnosis and less than 10% of those are diagnosed before puberty (Amory, 
Anawalt, Paulsen, & Bremner, 2000; Grace, 2004).  
KS infants are generally born without physical stigmata that would call attention 
to a genetic disorder and this contributes to post-natal under-diagnosis (Aksglaede, 
Petersen, Main, Skakkebaek, & Juul, 2007; Ross, et al., 2005). By early childhood, some 
KS boys show issues with developmental delay, speech, language and learning 
disabilities that may be the first sign of a medical problem (Graham, Bashir, Stark, 
Silbert, & Walzer, 1988; Porter, Gardner, DeFeudis, & Endler, 1988).  
It has been postulated that in KS boys, due to persistent developmental and 
learning struggles, there is a reduction in self-esteem that may lead to reduction in quality 
of life (Bruining, Swaab, Kas, & van Engeland, 2009; de Ronde, de Haan, & Drent, 2009; 
S. G. Ratcliffe, Bancroft, Axworthy, & McLaren, 1982; Simm & Zacharin, 2006).  
There is no clear understanding of how KS-related hypogonadism affects children 
before and during puberty (Ross, et al., 2005; Wikstrom, Dunkel, et al., 2006). Whether 
KS boys are androgen deficient prior to puberty is a controversial issue in the literature 
and among clinicians (Wikstrom, Dunkel, et al., 2006). It is also unclear how androgen 
deficiency is responsible for the characteristics and symptoms associated with KS 
(Bojesen & Gravholt, 2007; Wikstrom & Dunkel, 2008; Wikstrom, Dunkel, et al., 2006). 
There are currently no professional guidelines that direct clinicians about how or when to 
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treat androgen deficiency in children that has led to the controversial use of androgen 
therapy by some clinicians. 
  
Background and Significance 
KS occurs only in males is characterized in men by eunuchoid body habitus, 
sparse body hair, gynecomastia, small testes, azoospermia and reproductive hormone 
abnormalities (Bojesen & Gravholt, 2007; Lanfranco, et al., 2004; Visootsak & Graham, 
2006).  The systematic destruction of testicular tissue results in the progressive 
suppression of testosterone production and in turn, hypersecretion of the gonadotrophic 
hormones, FSH and Luteinizing Hormone (LH), a condition known as 
hypergonadotrophic hypogonadism (Aksglaede, Andersson, et al., 2007; Aksglaede, et 
al., 2006).  
 Speech and language delays (Collacott, Mitchell, Dawes-Gamble, Young, & 
Duckett, 1990; Graham, et al., 1988; van Rijn, et al., 2007; Zeger, et al., 2008), learning 
disabilities (Rovet, Netley, Keenan, Bailey, & Stewart, 1996) and behavioral disorders 
(Boone, et al., 2001; Geschwind, Boone, Miller, & Swerdloff, 2000; Giedd, et al., 2007; 
Hecht & Hecht, 1990) throughout the lifespan have been also been reported as part of the 
clinical picture.  
Much of the scientific literature on KS is comprised of reviews, case reports, case 
series, and data studies with small sample sizes. There are fewer than 20 data driven 
studies on children with KS.  The current literature on KS children offers limited 
descriptive information on physical characteristics, reproductive hormones, body 
composition, bone mineral density, neurocognition and psychoeducational profiles.  
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There are no studies to date that examine KS phenotype in childhood through the peri-
pubertal age range and its relationship to psychosocial health and reproductive hormones. 
Furthermore, current literature lacks a description of cardiometabolic and bone 
biomarkers in KS during childhood. There are also currently no reports of randomized 
control trials to assess whether testosterone replacement therapy causes improvement in 
physical or psychosocial health. 
 
 Compromised Health in KS Adults 
  It is presumed that the presence of the supernumerary X causes the testes to fail, 
bringing about androgen deficiency. As puberty approaches, androgen deficiency causes 
downstream effects on the body in adults. The arrest of full reproductive maturation is 
associated with the development of physical and psychological characteristics commonly 
seen in KS (Mandoki, Sumner, Hoffman, & Riconda, 1991; S. Ratcliffe, 1999; Wikstrom, 
et al., 2004).  KS continues to be a misunderstood condition for due to delayed diagnosis 
and co-occurring conditions such as attention deficit hyperactivity disorder (ADHD) and 
speech/language delay that may mask underlying genetic explanations for physical, 
psychological or social problems in life (Abramsky & Chapple, 1997; Grace, 2004).  
While men with KS are generally tall and appear slender, recent studies point to 
abnormalities in body composition (Bojesen, Host, & Gravholt, 2010; Bojesen, 
Kristensen, et al., 2006; Ishikawa, Yamaguchi, Kondo, Takenaka, & Fujisawa, 2008). 
Increased body fat, especially visceral fat may lead to development of insulin resistance 
and dyslipidemia in KS (Bojesen, Kristensen, et al., 2006; Pei, Sheu, Jeng, Liao, & Fuh, 
1998; Roemmich, Huerta, Sundaresan, & Rogol, 2001; Yesilova, et al., 2005). There is 
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an emerging body of work suggesting that unhealthy distribution of body fat in KS men 
is associated with insulin resistance and dyslipidemia. These body composition and 
metabolic features may contribute to increased risk for the development of Type II 
Diabetes, early cardiovascular disease and reduced life expectancy (Bojesen, Juul, 
Birkebaek, & Gravholt, 2004; Bojesen, Juul, Birkebaek, & Gravholt, 2006; Bojesen, 
Kristensen, et al., 2006; Lichiardopol, Mota, & Panus, 2004; Ota, et al., 2002; Park, et al., 
2004).        
A growing body of work in adults with KS suggests that they suffer from 
premature bone loss (Bojesen, Birkebaek, et al., 2010; Ferlin, Schipilliti, Di Mambro, 
Vinanzi, & Foresta, 2010).  Moreover, osteopenia and early osteoporosis has been 
associated with bone fracture, bone and joint pain and decreased mobility. (Breuil & 
Euller-Ziegler, 2001; De Rosa, et al., 2001; Horowitz, et al., 1992; Luisetto, et al., 1995; 
Wong, Pun, & Wang, 1993).  
The onset of metabolic syndrome and bone disease contribute to poor health and 
may adversely affects an individual’s life potential, quality of life, and mental health 
(Lanfranco, et al., 2004; Nielsen & Pelsen, 1987; Zastowny, Lehman, & Dickerson, 
1987).   
Since over 90% of individuals with KS are not diagnosed until adulthood, delayed 
diagnosis and intervention may result in metabolic, bone and psychosocial consequences 
that place limits on their overall health and well-being. For children diagnosed with KS, 
the opportunity exists for better understanding and possible early interventions that may 







The theoretical framework that guided this study was an adaptation of Engel’s 
Biopsychosocial Model of Health and Illness (BPS). The dominant medical approach to 
disease throughout history has been through a biomedical lens, leaving little room for the 
social, psychological and behavioral dimensions of illness (Engel, 1977). The biomedical 
model of disease assumes that “disease” can be accounted for by measureable biological 
variables; those related to somatic manifestations and biologic symptoms (Engel, 1977). 
In the 1970’s George Engel, an internist with a background in psychiatry, called for a 
new model of health that took into account how patients experience their illnesses (Engel, 
1977).  
 Engel (1997) explains the new model of understanding health in this way: 
Biopsychosocial thinking aims to provide a conceptual framework suitable for 
developing a scientific approach to what patients have to tell us about their illness. 
(p.523). 
 
Engel’s model took a holistic view that conceptualized three domains of health: 
biological, psychological and social.  He proposed that individual health factors within 
these domains bear upon individuals as they experience disease or a health condition.  
The Engel’s Biopsychosocial Model broadened the former traditional view of disease to 
create a viewpoint that focused on the concept of health and well being of the entire 
person (Borrell-Carrio, Suchman, & Epstein, 2004; Engel, 1977)  
 
Figure 1.1 presents Engel’s Biopsychosocial Model depicting the intersecting 
relationships of biological, psychological and social domains of a person’s health or 






















The general BPS model shown in Figure 1.1 illustrates the state of overall health 
as the intersection among biological psychological and social domains.  The BPS general 
model provides a structure for the understanding of overall health, but does not convey 
the domain relationships in term of health compromise. 
  For this dissertation study, Engel’s general BPS Model was adapted to explore 
specific aspects of health compromise associated with the biologic, psychological and 
social aspects of KS. In order to apply KS-specific dimensions of health compromise, 
each domain was examined separately, identifying specific features and clinical 
phenomena of KS that would naturally fall into each domain.  Figure 1.2 presents an 
adapted BPS model showing KS health characteristics and the reciprocal relationships 





















Figure 1.2 KS-related Health Characteristics Contributing to Health Compromise 

















The adapted BPS model explains how biogenetic features of KS might be 
associated with psychological manifestations of the condition.  For example, in KS 
individuals with psychological features and symptoms, behavior may reciprocally affect 
the biological features via poor diet, and/or poor therapeutic adherence to medication or 
cognitive therapies due to underlying depression and poor self-esteem.  The biological 
and psychological aspects of this model are related to the social aspect of health as 
physical characteristics, androgen deficiency, learning disabilities, behavior problems and 
self-esteem impact upon social interactions.  Ineffective and stressful social interactions 
then, in turn, affect the psychological and physical features of KS. 
To better understand the phenomena under study in children and to further 
explore the health compromise relationships, the adapted BPS model was integrated with 
a theoretical approach to the understanding of human development known as 
developmental contextualism presented in Figure 1.3.  Developmental contextualism 
presents a model of human life among multiple levels of organizational factors and 
accounts for reciprocal relations among biology, psychology, social groups and culture 
(Bronfenbrenner, 1979; R. M. Lerner, 1982; R. M. Lerner & Galambos, 1998). Individual 
development may be accounted for due to contextual interplay between physical and 
emotional development. Individual development is affected by outside forces such as 
social background, culture, family composition, socioeconomic factors, personal life 
experiences and influences of society (Reese, 1991).  For individuals with any disease or 
condition, including KS, these developmental contexts may bear upon how they 
experience their symptoms and their daily lives. 
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 The developmental contextualism model offers a background for the 
understanding of reciprocal relations among biology, psychology, and social contexts 
also throughout the lifespan (R.M. Lerner, 2005).   Figure 1.3 shows the conceptual 




Figure 1. 3 The Biopsychosocial Model of Health Compromise in KS (adapted 











The Biopsychosocial Model of Health Compromise in KS takes the BPS model 
and superimposes it upon a developmental context.  Each child with KS has a unique 
developmental milieu in terms of how he experiences his condition. The family 
socioeconomic status and composition of its members may impact the medical and family 
attention the child receives. Cultural context may dictate how the family views the child’s 
condition; whether it is deserving of special attention or if it is stigmatizing and must be 
hidden. Society is a pervasive context for the person with a genetic condition like KS as 
individuals struggle with possible fear, distrust and perceived stigma as they navigate 
their life course. Finally, personal experience is a context that may shape how a person 
with KS perceives himself and his world. If a person with KS is met with lifelong 
physical, psychological and social challenges, it may affect how he functions in his 
everyday life. 
The Biopsychosocial Model of Health Compromise in KS was the conceptual 
framework used to provide structure for the development of the hypotheses for this study 
and to create a strategy for how to explore specific variables and their relationships with 
each other.  A directional map of study variables, shown in Figure 1.4 was composed to 
provide structure for examining the hypothesized relationships among biological, 










Figure 1.4 Directional Map of Hypothesized Relationships between health       
                   variables in KS 
 
 
    Using an adapted conceptual framework for integrating physical, psychological and 
social features associated with KS, this study examined the direction and strength of 
relationships among variables in the hypotheses. 
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Aims & Hypotheses 
Aim 1:  to examine the association between KS physical phenotype, reproductive 
and metabolic hormones and psychosocial health characteristics. 
 
Hypothesis 1.1:  KS physical phenotype as measured by the Klinefelter Syndrome 
Physical Phenotype (KSPHE) Score is inversely associated with scores for quality of life, 
self-concept, self-esteem and positively associated with depression. 
  
Hypothesis 1.2: Testosterone levels are positively associated with scores for quality of 
life, self-esteem and self-concept and inversely associated with depression.  
 
Hypothesis 1.3: There is an inverse association between testosterone levels and physical 
phenotype as measured by a KS physical phenotype .      
 
Hypothesis 1.4: Testosterone levels are negatively associated with total cholesterol and 
insulin resistance. 
Aim II:  to compare body fat and bone mass in a sample of KS boys with normative 
data from healthy boys. 
 
Hypothesis 2.1     Boys with KS have a higher proportion of body fat as measured by  
                                 Dual Energy Xray Absorptiometry (DEXA) compared to healthy                 
                                 age-matched boys. 
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Hypothesis 2.2     Boys with KS have lower bone mass as measured by DEXA       
compared to healthy age-matched boys.  
 
The first aim of this study was explored using a descriptive observational study of 43 
boys.  The second aim of this study was accomplished with a retrospective medical 
record review of bone mineral density and body composition data from the medical 
records of 20 boys, 7 of whom participated in the observational study. 
 
Summary 
Presently, there is a large gap in knowledge about the health features and well-
being of children living with KS. This syndrome represents a prevalent sex chromosome 
disorder that manifests symptoms of testicular failure in childhood, with full expression 
beginning in puberty. Existing evidence in adults shows that KS adversely affects other 
non-reproductive health parameters including body composition, bone mineral density 
and psychosocial well-being.  
This exploratory study, examined, for the first time, associations among KS 
physical phenotype, reproductive hormone profiles, cardiometabolic and bone biomarkers 
as well as psychosocial health characteristics in a sample of KS boys between the ages of 
8 and 18 years. With the advent of pre-natal screening (Goodner, 1973; Robinson, 
Bender, & Linden, 1989) and the recognition of a significant number of children with KS 
diagnosed with developmental delay and behavior disorders (Visootsak & Graham, 
2006), the opportunity now exists to better define the nature and impact of arrested 
reproductive development on the general health and well-being of pediatric KS patients.  
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Furthermore, such knowledge is needed to better determine the appropriate timing of 
potential hormone replacement.  
   This dissertation was comprised of two studies. The first was a cross-sectional 
study of phenotype, hormones, cardiometabolic and bone biomarkers and psychosocial 
health characteristics in 43 boys between the ages of 8 and 18 years. The second was a 
retrospective medical record review of bone mineral density and body composition in 20 
boys between the ages of 8 and 18 years of age. Seven boys from the first study were 






Review of the Literature 
 
A review of the literature was conducted regarding general descriptions of KS, 
genetic mechanisms for its occurrence, incidence, physical and neurocognitive 
phenotype, biological consequences and psychosocial characteristics.  Literature for this 
review was identified through a Medline, Pubmed and PsychInfo search with hand 
searches of select articles.  The search was conducted using keywords, “Klinefelter 
Syndrome or Klinefelter’s Syndrome”, “pediatric”, “adolescents”, “children”, 
“phenotype”, “physical traits”, “reproduction”, “testosterone”, “puberty” “metabolic”, 
“metabolic syndrome”, “body composition”, “bone”, “bone mineral density”, 
“psychological”, “psychiatric”, “quality of life”, “body image”, “self-esteem”, 
“depression”, “social”, and “psychosocial”. The purpose of this review was to synthesize 
and critique evidence on physical characteristics, reproductive hormones, 
cardiometabolic biomarkers, body composition, bone mineral density and psychosocial 
parameters as they relate to children and adolescents with KS. Citations were limited to 
full text English language entries between the publication dates 1942 to 2010.  
Definition of Klinefelter Syndrome 
Klinefelter Syndrome (KS) is a sex chromosome abnormality in males due to the 
presence of an extra X chromosome causing a trisomy of 47, XXY.  Originally described 
in 1942 by Dr. Harry Klinefelter, the additional X chromosome is associated with a 
variable phenotype that is characterized by eunuchoid body proportions (long legs with 
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short trunk), abnormal leg length and arm span, feminine distribution of body fat, bone 
density deficits, gynecomastia, and gonadal failure resulting in infertility.  This genetic 
syndrome is also associated with absent or decreased facial and body hair with small 
testes and penis (Bojesen & Gravholt, 2007; Bojesen, Juul, et al., 2006; Bojesen, Juul, & 
Gravholt, 2003; Visootsak & Graham, 2006; Wikstrom, Painter, Raivio, Aittomaki, & 
Dunkel, 2006). Progressive gonadal failure has been associated with the development of 
eunuchoid body habitus, changes in body composition, reduction of lean muscle and bone 
as well as the development of behavioral and psychosocial issues (Amory, et al., 2000; 
Bojesen & Gravholt, 2007; Lanfranco, et al., 2004; Simm & Zacharin, 2006; Temple & 
Sanfilippo, 2003; Visootsak, Aylstock, & Graham, 2001).  KS may occur as a pure 47, 
XXY sex aneuploidy, but can also occur with multiple X copies such as 48, XXXY and 
49, XXXXY (Visootsak, et al., 2001; Visootsak & Graham, 2006).  
 KS may also present in the mosaic form of 47, XXY/46, XY or a myriad of other 
combinations of multiple X copies (Bojesen & Gravholt, 2007; Klinefelter, 1986; 
Visootsak & Graham, 2006).  Mosaic forms of KS may bear upon variations in the 
physical, neurocognitive, and psychological characteristics of individuals depending on 
the number of supernumerary X’s in the karyotype and the number of somatic cells 
carrying the mosaic pattern (Boada, Janusz, Hutaff-Lee, & Tartaglia, 2009; Geschwind, 
et al., 2000). Studies that compared pure KS (47XXY) to mosaic karyotypes 
(46XY/47XXY) failed to support that mosaicism showed better cognitive profiles 
compared to pure KS (Netley, 1986; Netley & Rovet, 1982; Stewart, Bailey, Netley, & 
al., 1990). Dispute exists, however, in some of these studies due to very small sample 
sizes and failure to report the percentage of mosaicism within the samples. 
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 In addition to the physical characteristics associated with KS, the process of 
gonadal failure leads to a progressive reduction of testosterone production. As 
testosterone production wanes, even at low normal levels, evidence demonstrates that 
adult patients with KS undergo bone demineralization (Breuil & Euller-Ziegler, 2001; H. 
R. Choi, Lim, & Lee, 1995; De Rosa, et al., 2001; Horowitz, et al., 1992; Leifke E., 1998; 
Luisetto, et al., 1995; Seo, Lee, Oh, & Joo, 2007; Soyka, Fairfield, & Klibanski, 2000; 
Stepan, Burckhardt, & Hana, 2003) and changes in body fat distribution (Aksglaede, 
Molgaard, Skakkebaek, & Juul, 2008; Bojesen, Kristensen, et al., 2006; Lichiardopol, et 
al., 2004).   
Abnormal body composition and decreased bone mineral density in KS patients 
lead to increased risk for the development of metabolic syndrome (Bojesen, Kristensen, 
et al., 2006; Lichiardopol, et al., 2004), cardiovascular disease (Bojesen, Juul, et al., 
2006; Boos & Matfin, 2002; Lanfranco, et al., 2004), diabetes (Bojesen, Juul, et al., 2006; 
Isobe, et al., 1992; Ota, et al., 2002) and osteoporosis (Breuil & Euller-Ziegler, 2001; De 
Rosa, et al., 2001; Horowitz, et al., 1992; Luisetto, et al., 1995; Seo, et al., 2007).  
 
Prevalence of KS 
KS is one of the most common sex chromosome abnormalities, occurring with 
equal frequency in all races (Bojesen, et al., 2003). The prevalence of KS is estimated to 
be in the range of 1 in 500 to 1 in 1,000 male births (Bojesen & Gravholt, 2007; Bojesen, 
et al., 2003; Egozcue, Blanco, & Vidal, 2002; Rogol, 2003; Visootsak & Graham, 2006). 
While the incidence of KS is estimated to be roughly 0.2% of all live male births, less 
than 10% of males with KS are diagnosed before puberty with 25% of overall diagnoses 
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occurring during childhood or adulthood (Abramsky & Chapple, 1997).   Almost 75% of 
males with KS remain unidentified (Simpson, et al., 2003).  
 
Genetic Mechanism for KS 
The sex chromosome trisomy of 47, XXY may occur during Meiosis I, Meiosis II 
or during one of the first post-zygotic divisions in the course of early embryonic cell 
division. (Iitsuka, et al., 2001)  The supernumerary X occurs during non-disjunction and 
may be of maternal or paternal origin.  Paternal origin occurs in 50 to 60% of cases, 
while maternal origin is due to the remaining 40% to 50% (Lorda-Sanchez, Binkert, 
Maechler, Robinson, & Schinzel, 1992; MacDonald, et al., 1994).  Gene dosage from the 
presence of two X chromosomes is highly variable due to activation, inactivation or 
partial inactivation of one or both of them. (Lanfranco, et al., 2004; Zitzmann, 
Depenbusch, Gromoll, & Nieschlag, 2004).   
Characteristics associated with KS may be due to complex genetic mechanisms 
such percentages of mosaicism in somatic cells, polymorphisms of specific genes on 
either X chromosome, imprinting differences due to parental derivation of the 
supernumerary X and/or gene dosage of X chromosome genes that fail to inactivate 
(Geschwind, et al., 2000). Some variability in phenotype differences have been 
hypothesized to be attributable to androgen receptor (AR) gene polymorphism and the 
number of CAG (cytosine-adenosine-guanine) repeats in coding sequence on the gene. 
Responsiveness of the receptor to testosterone correlates inversely to the number of CAG 
repeats (Zitzmann, et al., 2004). KS individuals with shorter CAG repeats may have a 
better response to serum testosterone compared to those with longer CAG repeats. The 
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better response to circulating testosterone is proposed to be associated with less severe 
KS phenotype (Zinn, et al., 2005; Zitzmann, et al., 2004). Two studies that included 
children in their samples reported no overall cognitive differences associated with AR 
CAG length (Ross, et al., 2008; Stemkens, et al., 2006).  The results of these studies may 
be confounded, however, due to wide age-ranges in the samples as well as differences in 
natural and exogenous androgen exposure (Boada, et al., 2009).  
The parental origin of the extra X chromosome has also been studied to 
investigate whether differences exist in KS phenotype associated with maternal or 
paternal alleles.   Cognitive, motor and psychiatric features of KS, studies have not 
supported the theory that there are differences between KS individuals given the parental 
origin of the extra X (P. Jacobs, Hassold, Harvey, & May, 1989; P. A. Jacobs, et al., 
1988; S. Ratcliffe, Butler, & Jones, 1991; Thomas & Hassold, 2003).  
Biological Consequences of KS  
Growth and Development 
Infants with KS may appear normal at birth.  Mean height and weight generally 
fall within the normal range, although lower birth weights have been reported compared 
to siblings and controls (S. G. Ratcliffe, Butler, & Jones, 1990).  As age increases, height 
velocity increases in comparison to siblings and controls.  Boys with KS begin to show 
disproportionately long legs beginning in early childhood, resulting in the eunuchoid 
body characteristic associated with KS (Wikstrom, Painter, et al., 2006). Mean age of 
walking has been reported to be at 18 months of age without interventional therapy and 
12 months of age with therapy (Samango-Sprouse, 2001). Speech and language delay is 
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evident by 12 months of age with a reduction in phoneme development and coordination 
difficulties of oral musculature including lips and tongue (Samango-Sprouse, 2001). 
Language is also delayed to 18-24 months for KS boys compared to unaffected boys who 
begin to speak first words at 12 months of age (Graham, et al., 1988). Delayed speech 
and language continue throughout childhood with comprehension deficits when language 
is complex or abstract. This contributes to problems with reading and written 
composition (Graham, et al., 1988). KS has often been reported to be associated with 
mental retardation (Khalifa & Struthers, 2002; Rovet, Netley, Bailey, Keenan, & Stewart, 
1995) while IQ has also been reported to fall in the normal to low-normal range 
(Samango-Sprouse, 2001).  
Physical Phenotype 
The physical phenotype associated with KS includes tall stature, feminine-pattern 
fat distribution with absent or sparse body and facial hair (Amory, et al., 2000; Bojesen & 
Gravholt, 2007; Smyth & Bremner, 1998).  Small phallus and testes are typical findings 
on physical exam ((Bojesen & Gravholt, 2007; Klinefelter, 1986; Lanfranco, et al., 2004). 
Males with KS also may show gynecomastia, reduced upper body muscle mass with 
decreased upper body strength (Bojesen, Kristensen, et al., 2006). Other variable features 
may include hypertelorism, taurodontism, high arched palate, skeletal abnormalities, fifth 
finger clinodactyly and fine tremor of the hands (Simpson, et al., 2003; Visootsak & 
Graham, 2006).  
Prior to puberty, some of the physical abnormalities begin to emerge including:  
tall stature, long legs and slightly smaller testicular volume for age. Onset of puberty is 
typically normal with normal pituitary gonadal function (Salbenblatt, et al., 1985). In 
  24 
 
adolescence, taller stature may be evident with longer legs compared to torso. Arm span 
may or may not exceed height (Kamischke, Baumgardt, Horst, & Nieschlag, 2003). 
Decreased libido, potency and fertility are noted by KS individuals around the second 
decade (Lanfranco, et al., 2004) 
 
Reproductive System 
Hypergonadatrophic hypogonadism is one of the main mechanisms associated 
with physical and neurocognitive characteristics associated with KS. (Aksglaede, 
Andersson, et al., 2007; Aksglaede, et al., 2006; Wikstrom & Dunkel, 2008; Wikstrom, 
Dunkel, et al., 2006; Wikstrom, et al., 2004) Gonadal failure is the hallmark event that 
impairs the neuro-reproductive axis and causes a severe reduction in the capacity for KS 
males to produce testosterone (Lahlou, Fennoy, Carel, & Roger, 2004).  As a result of the 
loss of negative feedback, KS is characterized by abnormally elevated levels of 
gonadotropins (LH & FSH) at the onset of puberty.  Gonadal failure sets the background 
for reduced production of testosterone. Androgen deficiency is associated with many 
health problems in KS including loss of lean muscle, increased visceral fat, bone loss, 
azoospermia, increased risk for cardiovascular disease and increased depression (REF). 
 
Testosterone and KS Boys 
At birth, most KS infants appear phenotypically normal with the exception of 
some who have small phalluses, but not small enough to be categorized as 
“microphallus” (Ross, et al., 2005).  In non-affected male infants, there is a postnatal 
variable surge of testosterone at 2 to 4 months of age (Aksglaede, Petersen, et al., 2007).  
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KS infants may have a minimal or absent surge that may contribute to relatively small 
phallic length and this shows early evidence of androgen deficiency (Lahlou, et al., 2004; 
Ross, et al., 2005).  In the KS infant testes, Sertoli cells secret inhibin B and antimullerian 
hormone at normal levels, but Leydig cells show impaired production of testosterone 
(Lahlou, et al., 2004). This suggests that mechanisms causing gonadal failure are in 
progress well before the onset of puberty.   KS males enter puberty at about the same 
time as non-affected males, but the course of their pubertal development changes when 
gonadal failure takes place. (Aksglaede, et al., 2006; Bojesen & Gravholt, 2007; Rogol, 
2003; Wikstrom & Dunkel, 2008; Wikstrom, et al., 2004).  
Testosterone levels in KS boys remain in the low normal range and may persist 
whether or not they are treated with hormone replacement therapy (Okada, et al., 2004; 
Rogol, 2005; Ruvalcaba, 1989).  It is not clear, however whether this is based on 
treatment regimens, adherence to treatment or if there is an inherent resistance to 
testosterone. The reduced production of testosterone is thought to be due to a decline in 
the number of Leydig cells associated with the pathologic demise of the Sertoli cells. 
Testes become smaller as puberty advances due to progressive hyalinization of the 
seminiferous tubules with the loss of spermatogonia and apoptosis of Sertoli cells and 
reduction in volume of Leydig cells (Aksglaede, Andersson, et al., 2007; Aksglaede, et 
al., 2006). In adults, gonadal failure causes androgen deficiency, with aspermatogenesis 
and is associated with reduced libido.,  
 A controversy exists about the nature and timing of androgen deficiency in boys. 
In 2006, Wikstrom et al. followed the testosterone levels in 14 KS boys between the ages 
of 10 and 14 years for 4 to 37 months. They concluded that serum testosterone levels rose 
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as expected and remained within the normal range throughout their follow-up.  The 
authors suggest that if boys are not androgen deficient there may be no need for androgen 
supplementation in early puberty (Wikstrom, Dunkel, et al., 2006).  In a recent review 
article by Fennoy (2011), the author emphasized the absence of data in the literature that 
points to beneficial outcomes of testosterone in the prepubertal child.(Fennoy, 2011) and 
there is no documented benefit of using testosterone replacement therapy in pre-pubertal 
children. 
Body Composition 
         A few recent studies now suggest that body composition is altered in KS individuals 
(Bojesen, Host, et al., 2010; Bojesen, Kristensen, et al., 2006; Ishikawa, et al., 2008). 
Visceral fat is associated with insulin resistance, dyslipidemia and increased risk for the 
development of diabetes and cardiovascular disease (Makhsida N., 2005).  Adults with 
KS may or may not show frank obesity in their body habitus (Bojesen, Host, et al., 2010).  
Even with lean appearing, eunuchoid body shape, evidence shows that men with KS have 
increased visceral fat (Aksglaede, et al., 2008; Ishikawa, et al., 2008; Pagotto, et al., 
2003).   
Three studies were identified that explored body composition and metabolic 
syndrome biomarkers related to KS.  Lichiardopol et al. (2004) using a cross-sectional 
design compared 31 untreated KS patients between the ages of 19 and 54 years of age 
with 31 healthy age-matched controls. The authors showed that hypercholesterolemia 
was present in 56.7% of the KS group and that hypercholesterolemia correlated with age 
and the magnitude of androgenic deficit. In addition, they observed that 35.5% of the KS 
patients were overweight and that 16.1% were obese compared to 9.7% of the control 
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group.  While none of the patients in this study met the criteria for diabetes, over 16 % of 
the KS group had glycemic values above 100 mg/dL. This study was one of the earliest to 
link clinical features of metabolic syndrome to the KS population.   
 Bojesen et al (2004), in a cross-sectional study, examined 71 patients over 18 
years of age with KS, half of whom received testosterone treatment.   KS patients were 
compared to 71 healthy control subjects.  The results of this study demonstrated that 44% 
of the men with KS had metabolic syndrome compared to 10% of controls. In addition, 
insulin sensitivity, androgen and high-density lipoprotein (HDL) were decreased in KS 
compared to controls. The authors also report that total fat-mass, MEASURED HOW. 
low-density lipoprotein cholesterol (LDL), triglyceride, C-reactive protein (CRP), leptin 
and fructosamine were increased in untreated KS patients.  The authors concluded that 
KS may cause changes in body composition, primarily through increased truncal fat and 
decreased muscle mass.   
      A recent cross-sectional study by Aksglaede et al (2008) represents a landmark report 
of bone mineral content and body composition in children.  Using a population of 18 
children with KS between the ages of 4 and 18 years of age, Aksglaede et al. examined 
lean body mass and body fat mass in a cross-sectional study. The authors concluded that 
increased body fat mass, despite normal lean body mass, suggested an unfavorable 
muscle/fat ratio.  Within this fairly young population, these investigators found that the 
unfavorable metabolic profile seen in adult KS may already be present in childhood.  
Although limited by small sample size and cross-sectional design, the authors postulated 
that increased body fat in pre-pubertal KS boys implicated a genetic link independent of 




Population studies in Denmark (Bojesen, et al., 2004) and Great Britain 
(Swerdlow, Higgins, Schoemaker, Wright, & Jacobs, 2005) have reported increased 
mortality risk due to diabetes and cardiovascular disease in KS men.  These recent 
descriptions of unfavorable metabolic parameters in adults and children challenge some 
of the traditional views of the classic KS physical phenotype of the tall, slender body and 
show that a majority of KS men have unhealthy body composition characterized by large 
amount of truncal fat and increased waist circumference (Bojesen, Host, et al., 2010).  
Further study on the physical and metabolic characteristics of KS, especially in 
childhood, is required in order to better characterize progression of metabolic risk and to 
identify ways in which to decrease mortality risk. There are no studies to date that have 
examined linkages between KS phenotype and cardiometabolic risks in childhood.  
Bone Mineral Density 
 Bone mineral density (BMD) and bone function are important health indicators.  
In childhood, the accrual of bone gained during adolescence is the main determinant of 
peak bone mass and is a predictor of an individual’s future risk for osteoporosis and 
fracture in older adults (Loro, et al., 2000).  
The physiological parameters of bone are now being understood to contribute 
much more to overall health status and are known to be intimately associated with human 
metabolism (Ferron, Hinoi, Karsenty, & Ducy, 2008; Lee & Karsenty, 2008b). There are 
many determinants of bone mass, including genetic, hormonal, nutritional and exercise 
factors.  These factors may be associated with low peak bone mass and loss of BMD 
(Soyka, et al., 2000).  Bone is now understood to have much more than structural 
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properties in the body and is known to be an integral part of the endocrine system (Lee, et 
al., 2007).  In men with KS, serum T is at the lower end of normal and 
dihydrotestosterone is also low.   Bone secretes the hormone osteocalcin, which 
participates in the regulation of blood sugar and fat deposition in the body. This hormone 
also contributes to the secretion and sensitivity of insulin in the body.  Histological 
studies showing that androgen receptors are thought to mediate the effects of T and that 
estrogen appears to be the more important sex steroid involved in skeletal maturation and 
mineralization (Soyka, et al., 2000).   
Bone formation and re-absorption involves complex endocrine interactions 
including the recently discovered regulation of insulin by the bone-derived hormone 
osteocalcin and the production of the hormones leptin and adiponectin by body fat (Lee 
& Karsenty, 2008a). Leptin and adiponectin have important roles in the formation and re-
absorption of bone as well as in weight control and reproduction (Gordon, Bachrach, 
Carpenter, Karsenty, & Rauch, 2004). 
Androgens play in important role in the formation of bone throughout the 
lifespan. In males, bone metabolism is regulated by testosterone in an indirect fashion 
due to aromatization to estrogens. This process interacts directly with bone formation 
through the androgen receptor. During puberty, testosterone acts to promote periosteal 
bone formation (Jackson, et al., 1987) and then to reduce bone resorption during later life 
(Dupree & Dobs, 2004). Testosterone, therefore, plays a central role during critical stages 
of bone formation and maturation.  Androgen deficiency associated with KS in adults is a 
key risk factor for the development of early osteoporosis (Bojesen, Birkebaek, et al., 
2010; De Rosa, et al., 2001).   
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Early development of osteopenia and the later development of osteoporosis have 
been observed in KS adults (Bojesen & Gravholt, 2007; Breuil & Euller-Ziegler, 2001; 
Horowitz, et al., 1992). Several investigators report positive correlation between BMD 
and testosterone levels in unaffected men and those with KS (Foresta, Ruzza, Mioni, 
Meneghello, & Baccichetti, 1983; Horowitz, et al., 1992; Seo, et al., 2007). 
Osteopenia in KS is associated with androgen insufficiency and androgen receptor 
resistance.  There are no studies on KS that follow bone health longitudinally from the 
early stages of bone loss. Loss of bone and muscle are major features of hypogonadism. 
In terms of bone loss, both cortical and trabecular bone are affected by androgen 
deficiency (Leifke, et al., 1998).  Interventional treatments with testosterone replacement, 
bone mineral supplementation and bone preservation medications early in the disease 
process may prevent or diminish negative health outcomes (Leifke, et al., 1998; 
Ruvalcaba, 1989; Seo, et al., 2007).  The reduction of BMD in KS patients may represent 
a more complicated picture of bone physiology alone, however.  It may play a key role in 
how body fat distribution and biomarkers of metabolic syndrome work together in 
creating risks for diabetes and cardiovascular disease in patients with KS (Luisetto, et al., 
1995).  
Horowitz et al. in 1992 conducted a hallmark cross-sectional study investigating 
forearm BMD, forearm body fat and bone-related biochemical markers in a group of 
subjects between the ages of 19 and 68 years of age with KS compared to age matched 
controls. In the KS group, 12 of the 22 received sex hormone therapy. BMD in this study 
was accomplished with the use of single photon absorptiometry. The authors reported 
that forearm BMD was lower in the KS group compared to the normal group and that 
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forearm fat content was higher in the KS group. They also reported that serum 
osteocalcin and T were lower in the KS group, while ionized calcium and the ratio of 
urinary hydroxyproline/creatine were higher in the KS group. The authors attributed these 
findings to decreased bone formation and increased bone resorption in the KS group. This 
study was one of the first to study BMD and body composition and to compare these 
findings among treated versus untreated KS and a healthy control group. The inverse 
relationship between the extent of the bone deficit and the serum T in the KS group 
suggests that osteoporosis in KS is more likely due to hypogonadism and is not genetic in 
origin. This study was limited, however due to fairly small overall sample size (N = 44) 
with 22 in the KS group stratified into groups based upon prior or current treatment with 
testosterone.  
In 2006, Seo et al. conducted a cross-sectional comparison of 40 adult KS 
subjects without a history of testosterone treatment compared to 20 healthy controls. As 
expected, in the KS subjects, results showed that testosterone was low while FSH and LH 
were high.  Compared to controls, BMD at the lumbar spine, femoral neck and Ward’s 
Triangle was significantly lower mean.  The investigators concluded that low testosterone 
may cause inadequate bone mineral development in KS subjects and recommended that 
testosterone replacement may be necessary to prevent bone mineral deficiency and future 
risk of fractures. This study was limited, however, by its small sample size and lack of 
comparison with a testosterone treated KS group.  
In 2007, Aksglaede et al measured body composition and bone mineral density in 
a sample of 24 children and adolescents (18 untreated with testosterone and 6 treated).  
Using local DEXA norms from healthy school children in Denmark, they concluded that 
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boys with KS had increased body fat mass despite normal lean body mass and bone 
mineral density for the group was normal. While this study showed no statistical 
differences in bone mineral density between treated and untreated boys, they noted that 
whole body bone mineral content and lumbar bone mineral density were higher in the 
group of treated boys. This study was limited by small sample size and unequal group 
sizes with respect to treatment status.   
Amory et al (2000) noted that assessment of BMD in childhood is complicated by 
the lack of normative data in large populations of children. There is now a large set of 
normative data on body composition and BMD in healthy children that employed Dual 
Energy X-ray Absorbtiometry (DEXA) as the form of measurement (Kalkwarf, et al., 
2007; Margulies, et al., 2005).  Since this normative data set was published, a number of 
studies have used these norms to compare BMD in children with other chronic conditions 
such as asthma (Witt, 2007) and HIV (Arpadi, et al., 2002). There is no study to date that 
compares the BMD of children with KS to these norms. 
Psychological Consequences of KS 
Studies in the early 1940’ s and 1950’s on cognitive and behavioral phenotypes 
suggested that there were increased rates of intellectual and mental health disabilities in 
KS men.  These conclusions, however, were severely biased due to ascertainment factors 
since much of the data were collected in mental health hospitals, long-term care 
institutions and correctional facilities (Boada, et al., 2009). Since the prevalence of 47 
XXY is high in the general population, these early studies drew conclusions that were not 
representative of the population at large. Later studies on intelligence and behavior were 
conducted on unselected samples of patients who were identified via newborn screening 
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programs in Denver, Edinburgh, Denmark and in other sites around the world (Bojesen, 
et al., 2003; Carothers & Filippi, 1988; S. G. Ratcliffe, et al., 1990; Robinson, Bender, 
Linden, & Salbenblatt, 1990).   Collaboration and pooling of results from these studies 
suggested that intellectual and behavioral features of KS patients were much less 
compromised than portrayed by the earlier studies. These later studies were of higher 
quality due to the reduction in selection bias, the prospective design of these studies and 
long-term follow-up of their subjects. Additionally these studies controlled for 
socioeconomic status, parenting styles, family composition and other environmental 
factors by using sibling controls.  
Since the mid 1990’s other studies have focused on the relationships of cognitive 
outcomes to specific genetic factors such as parental origin of the extra X chromosome 
(Boone, et al., 2001; DeLisi, et al., 2005; Ross, Zeger, Kushner, Zinn, & Roeltgen, 2009; 
van Rijn, Swaab, Aleman, & Kahn, 2006; Zinn, et al., 2005; Zitzmann, et al., 2004; 
Zitzmann, Gromoll, & Nieschlag, 2005). The study samples were drawn from clinical 
populations and KS advocacy groups that made them subject to ascertainment bias in the 
interpretation of their outcomes. Generally, it is now understood that the intelligence in 
boys with KS is normal to low-normal with impairments limited to very specific areas of 
cognition such as language and executive functions (Geschwind, et al., 2000; Khalifa & 




Specific Learning Issues 
 
While intellectual capabilities of KS individuals show low normal to normal 
intelligence, specific cognitive impairments exist such as poor reading, spelling and 
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writing in the early grades (Graham, et al., 1988; Walzer, Bashir, & Silbert, 1990). After 
age 10, educational struggles include math skills, causing many KS boys to fall behind 
academically compared to their peers and requiring special education (Stewart, et al., 
1990; Walzer, et al., 1990).  
The specific learning issues associated with KS appear to be language-based due 
to delays in language developmental milestones (Bender, Linden, & Robinson, 1993; 
Bender, Puck, Salbenblatt, & Robinson, 1986; Rovet, et al., 1996).  
While KS boys may fall behind in educational achievement, many boys succeed 
at least through secondary school and some progress on to college (Nielsen & Pelsen, 
1987). Learning problems may cause reduced occupational potential compared to non-
affected males (Nielsen, Pelsen, & Sorensen, 1988). This may affect overall self-esteem 
creating future socio-economic barriers.  
Testosterone replacement therapy has been reported to improve mood and 
behavior, goal-directed thinking and self-esteem while reducing fatigue and irritability in 
KS men (Myhre, Ruvalcaba, Johnson, Thuline, & Kelley, 1970; Nielsen, et al., 1988). A 
recent study, however, by de Ronde et al, reported that quality of life in KS adults on 
testosterone therapy was lower than a non-affected reference group, and that KS patients 
with higher educational achievement had better quality of life(de Ronde, et al., 2009). 
  
Speech, Language and Interpersonal Communication 
          Speech and language problems are common in 70 to 80% of boys with KS 
(Bender, Linden, & Robinson, 1989; Graham, et al., 1988; S. G. Ratcliffe, et al., 1982). 
Speech may be significantly delayed and show difficulties in articulation, word retrieval 
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and phonemic processing (Robinson, et al., 1990).  In addition to expressive language 
problems, receptive language problems such as phoneme discrimination, auditory 
processing speed and comprehension have also been noted (Bender, et al., 1989; Graham, 
et al., 1988; Walzer, et al., 1990).  
            Auditory processing and poor verbal memory are thought to be central to the 
learning deficits seen in KS (Geschwind, et al., 2000). Social communication depends in 
large part, on language transactions between people. In addition to the skills of language 
comprehension and verbal expression, oral language involves skills beyond semantic 
language (van Rijn, et al., 2007). 
             Communicative intention is often expressed in the rhythm and emphasis of not 
only what is said, but how it is said (van Rijn, et al., 2007). van Rijn et al. in 2007 
conducted a study with KS adults in whom they measured emotional content of speech 
conveyed by prosody (rhythm and emphasis) or the semantics of sentences. While 
general intelligence did not differ between the KS group and an unaffected group of 
controls, results showed that KS subjects had difficulty discriminating emotions in verbal 
content of speech as well as in tone of voice. Deficits in the ability to interpret the 
communication of others may underlie social problems experienced by those with KS 
(van Rijn, et al., 2007; van Rijn, Swaab, Aleman, & Kahn, 2008). 
Behavior and Emotion     
 
       Boys with KS have been described as immature, insecure, and shy with poor 
judgment and inappropriate assertiveness (Bancroft, Axworthy, & Ratcliffe, 1982; 
Boone, et al., 2001; Geschwind, et al., 2000; S. G. Ratcliffe, et al., 1982; Simm & 
Zacharin, 2006).  
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In 2009, Bruining et al conducted psychiatric assessment study on 51 children and 
adolescents.  They found a large classification of psychiatric diagnoses including 
attention deficit hyperactivity disorder (63%), depression (24%), generalized anxiety 
disorder (14%), and autism spectrum disorder (27%) (Bruining, et al., 2009). This work 
supported the findings of van Rijn et al in 2008 who found in a sample of KS adults, that 
48% would classify as having autism spectrum disorder with significant emotion 
regulation problems and social distress (van Rijn, et al., 2006, 2008). 
 
Social Consequences of KS 
Learning issues, ineffective communication skills, inattention problems and social 
anxiety contribute to social withdrawal in KS (Bender, Harmon, Linden, & Robinson, 
1995; Geschwind, et al., 2000). Many individuals with KS report having few friends, 
poor family relations and few social activities (Nielsen & Pelsen, 1987). Problems with 
behavior regulation such as impulsivity and aggression also create barriers for social 
relationships (Bender, et al., 1993; Boone, et al., 2001; Geschwind, et al., 2000; van Rijn, 
et al., 2006). While individuals with KS have been described as passive or shy, there are 
also reports of paradoxical behavior outbursts and difficulty establishing and maintaining 
relationships (Geschwind, et al., 2000; Samango-Sprouse, 2001). KS adolescents have 
reported problems with peer relationships and less interest in sexual attractions 
(Theilgaard, 1984).   
Concentrated frustration due to combinations of communication difficulties, 
learning disabilities, and poor self-perception sets a background for social and 
psychological difficulties (Mandoki & Sumner, 1991; Mandoki, et al., 1991).  School-
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function problems and sports-related physical limitations due to reduced upper body 
strength may erode self-esteem and lead to symptoms of depression (Ross, et al., 2008; 
Rovet, et al., 1996). Body image issues may arise as young KS boys compare their bodies 
to those of their peers (Davison & McCabe, 2006; Gilliland, et al., 2007). 
 
Psychosocial Health & Adaption in KS 
 
Psychosocial health in KS adults is affected by intelligence, academic and 
vocational success, ability to communicate effectively, and to manage emotions and 
behavior (Simm & Zacharin, 2006).  The integration of these characteristics intertwine 
with the dynamic process of day-to-day living which requires continuous adaption of 
each person’s inner resources in response to environmental and interpersonal relationship 
demands (Geschwind, et al., 2000).   
Bender et al in 1995 described 13 KS boys who struggled through adolescence 
with academic challenges, impaired social interactions and behavior control problems 
(Bender, et al., 1995). They noted that few of the children in this study were involved in 
extracurricular activities during the school years. The authors also noted that challenges 
in academic and motor skills prevented the KS boys from distinguishing themselves in 
school or in competitive sports. The authors concluded that these obstacles contributed to 
loss of self-confidence and identification with social groups comprised of other low-
achieving peers.  
Geschwind & Dyker in 2004 conducted a series of pilot studies on personality and 
emotional issues in 15 KS adults. The authors concluded that KS individuals are not 
motivated by a need for independence or social prestige. Early struggles with poor 
academic performance, impaired communication and limited social interaction may lead 
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to lifelong problems with poor self-esteem, poor quality of life and depression (de Ronde, 
et al., 2009). 
 
Literature Gaps 
  KS-related hypogonadism has been linked to biological, neurocognitive and 
psychosocial aspects of life in individuals with KS. The KS phenotype is heterogeneous 
with variations in severity (Simpson, et al., 2003). While the literature reports 
characteristics commonly associated with KS, there is no systematic method of 
measuring severity or pattern of clinical characteristics. 
 In adults, increased body fat mass, particularly truncal adiposity has been shown 
to be associated with the development of metabolic syndrome, insulin resistance, diabetes 
and cardiovascular disease. There are few studies that assess reproductive hormone 
characteristics and cardiometabolic health risks in KS children. As hypogonadism 
progresses throughout the lifespan, evidence have also shown that increased bone de-
mineralization is related to the development of osteoporosis, fractures and loss of 
mobility. Current evidence is lacking on bone mineral density measurement on children 
with KS.   
Domains of research on KS have yet to examine or create linkages between 
physical, psychological and social features of this condition, especially early in life. 
Methodological weaknesses of current research on KS include small sample sizes, lack of 




There is a large gap in the literature of studies that create an integrated description 
of children with KS.  There are no studies to date that explore how KS affects self-
esteem, body image, or depression. With the exception of one study in KS adults, there is 
limited evidence on how KS affects quality of life in adults or children or if testosterone 
levels are related to psychosocial health. The description of quality of life, self-esteem, 
self-concept and depression in children will add new understanding about psychosocial 
health in KS boys. The results of this study may better guide future research therapies 








For Aim 1, characteristics of the KS phenotype, reproductive hormones, 
cardiometabolic, bone biomarkers and psychosocial health parameters were investigated 
using a cross-sectional descriptive study of 43 boys.  In Aim II, a retrospective review of 
medical records of 20 boys (7 of whom participated in the cross-sectional study) was 
conducted to examine bone mineral density and body composition characteristics of boys 
with KS. 
Protection of Human Subjects 
 Prior to initiation, the study protocols were approved by the Columbia University 
Medical Center Institutional Review Board. For the cross-sectional study with children 
17 years of age and younger, parents provided informed consent and children provided 
informed assent. Subjects who were 18 years of age provided informed consent.  Consent 
was not necessary for the medical review study. 
Subject Recruitment 
After approval by the Columbia University Medical Center Institutional Review 
Board, a patient sample of study participants was recruited for Aim I from the following 
sources: a pediatric endocrine specialty practice at Columbia University Medical Center 
(CUMC); a national KS Support and Advocacy Association known as Knowledge, 
Support & Action (KS&A); two local KS support groups (The New York Area KS 
Support Organization, the New Jersey/TriState Area KS Support Organization) and the 
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Central Texas Regional KS Support Group. This study was also registered with a 
professional online recruitment search engine, “RecruitSource®” 
(http://www.recruitsource.com) that assists researchers in identifying potential research 
subjects.  This service screens all potential subjects using an online product entitled, 
“PrivateAccess™” (http://www.privateaccess.info) that allows potential recruitment 
candidates to select and store private directives that determines who may contact them for 
participation in a particular study. Potential candidates choose whether they are interested 
in recruitment and are given contact access to the researcher. Letters and recruitment 
brochures were mailed to local and regional pediatric endocrinologists, geneticists and 
genetic counselors. The Pediatric Endocrine Nursing Society notified its members via 
email and on its website of the recruitment search for this study. Finally, this study 
recruited from its own recruitment website: http://www.47xxyklinefelteryouth.com.  A 
recruitment advertisement was placed for 1 week with the online social networking site, 
Facebook ™, that directed internet traffic to the study website. 
Sample Size 
 
Sample size for the cross-sectional study was based upon a moderate correlation 
of at least 0.40 between the clinical characteristics and psychosocial variables as 
observed in studies of health-related quality of life and polycystic ovary syndrome (Hahn, 
Janssen, et al., 2005; McCook, Reame, & Thatcher, 2005). For a two-tailed t-test with 
alpha at .05, 46 subjects were required.   
For Aim II, the retrospective chart review, records were selected of KS patients 
who attended a pediatric endocrine practice at Columbia University Medical Center 
between 2006 and 2010.   
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Sample and Setting 
A patient sample of KS boys between the ages of 8 and 18 years of age was 
recruited for the cross-sectional study. The sample for the retrospective bone mineral 
study was derived from a retrospective review of clinical medical records of 20 boys with 
KS between the ages of 8 and 18 years. The cross-sectional study was conducted at the 
Pediatric Research Outpatient Unit of the Irving Institute for Clinical and Translational 
Research at CUMC, at the KS&A Families Conference in Mason Ohio and during home 
visits. Private examination rooms were secured in each setting. Of the 43 subjects who 
participated in the study, data were collected at the Irving Center for Clinical & 
Translational Research Pediatric Division at CUMC (n = 22; 51%), at the participant’s 
home (n = 16; 37%) and during the 2010 KS&A Families Conference in Ohio (n = 5; 
12%). 
Inclusion and Exclusion Criteria 
Aim I: Cross-sectional Study 
Boys with a confirmed karyotype of 47XXY or mosaic 47 XXY/46XY between 
the ages of 8 and 18 years of age were eligible to participate for the cross sectional study.  
Subjects and their participating parent were required to be English-speaking and able to 
read at the third grade level. Subjects were excluded from participation of they failed to 
meet inclusion criteria, e.g., not able to read at the third grade level.  
 
Aim II: Retrospective Review 
Records were included if patients were between the ages of 8 and 18 years of age 
at the time of the visit, had a bone mineral density scan performed at the Obesity 
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Research Center at St. Luke’s Roosevelt Hospital in New York City and had a laboratory 
assessment of serum testosterone within 6 months of the bone mineral density scan. 
Study Procedures for Aim I:  Cross-sectional Study 
Potential subjects for recruitment were identified and invited to participate by the 
investigator.  If the potential subject and/or parent of the subject expressed interest in the 
study, they were given or emailed the IRB-approved recruitment brochure (Appendix A) 
and directed to the study’s recruitment website: http://www.47xxyklinefelteryouth.com 
for more information. If the potential subject and/or parent of the subject chose to 
participate, an appointment was made to meet with the investigator for a study visit at a 
site most convenient for them. Prior to the study visit, each family was emailed an 
instruction sheet (Appendix B).  
The protocol began with explanation of the study and presentation of consents 
and/or assents and HIPAA information. The investigator explained the research study and 
responded to questions. After questions were answered, if the parent and child agreed to 
participate, parents and subjects over 18 years of age provided written informed consent 
and children between the ages of 8 and 17 signed assent forms.  Each consent and assent 
was then co-signed by the investigator.  A copy of the consent, assent and Health 
Insurance Portability and Accountability forms was given to the parent and minor child 
or to the subject.  
For children evaluated at the Pediatric Research Center, the blood draw was 
conducted first, followed by a short breakfast.  Either during breakfast, or after breakfast, 
the child responded to the psychosocial questionnaires  (Appendix D) while the parents 
responded to the demographic questionnaire (Appendix E) in a separate room. When the 
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questionnaires were completed, the child changed into an examination gown and the 
physical examination with anthropometric measures was conducted. Parents were present 
for the physical examination unless the child expressly requested privacy and the parent 
agreed. Following the physical examination, the child dressed back into street clothes. If 
the child was examined off-site, visit began with questionnaires, followed by the physical 
exam. The parents were then given a requisition for hormonal and cardiometabolic 
laboratory testing and directed to have blood drawn at their nearest Laboratory 
Corporation of America (LabCorp) site.  
At the end of the visit, a $25 American Express Gift Card was presented to each 
child for his participation. The family was invited to ask questions.  When all questions 
were sufficiently answered, the study visit was ended. Time commitment for 




Table 3.1 Protocol Time Commitments for Participants 










Changing into an Exam Gown  5 
Physical Exam 20 
Changing into Street Clothes  5 
Post-Visit Questions 
Giving Subject Compensation 
 
10 
Total Study Visit Time 105 
Note. Off site visits did not include time for blood draw  
 
Study Procedure for Aim II: Medical Record Review Study 
De-identified data were extracted from the medical records of 20 patients with 
KS. Seven of these 20 patients later took part in the KS descriptive observational study. 
Data was entered into a de-identified Excel spreadsheet in preparation for analysis. Bone 
mineral density for all subjects was assessed using GE Lunar Prodigy DEXA equipment 
at the New York Obesity Center located at St. Luke’s Roosevelt Hospital in New York 
City within the past 4 years.  Serum testosterone for all subjects was collected as part of 
their normal care within 6 months of receiving the DEXA evaluation. Esoterix 
Laboratories in Calabasas, California measured serum testosterone using the assay 
sensitivities and coefficients as shown in Table 3.3. For subjects included in the medical 
record review, DEXA values for percent body fat, total bone mineral content and bone 
mineral density were compared to establish pediatric DEXA norms according to age and 
ethnicity (Kalkwarf, et al., 2007).  Data were analyzed using descriptive statistics and 
univariate linear regression to examine the relationship between Anterior-Posterior (AP) 
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Lumbar Spine density, total body bone mineral density (TBBMD), percent body fat as 
assessed by Dual Energy X-Ray Absorptiometry (DEXA), and serum testosterone levels. 
Study Variables 
Study variables for Aim I, consisting of demographic information, clinical 
observations, anthropometric measures, reproductive hormones, cardiometabolic and 
bone biomarker values and psychosocial health measures are summarized in Table 3.2. 
Variables for Aim II are shown in Table 3.3. 
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Table 3.2 Summary of Study Variables: Aim I 
Variables Measurement 
Phenotype Klinefelter Syndrome Phenotype Index* 
Reproductive Hormones 
     Testosterone 
     Lutenizing Hormone (LH) 
     Follicle Stimulating Hormone (FSH) 
     Estradiol 
     Sex Hormone Binding Globulin (SHBG) 









     Total Cholesterol 
     High Density Lipoprotein 
     Low Density Lipoprotein 
     Glucose 
     Insulin 
     Homeostasis Model Assessment 
 






Insulin uIU/mL X Glucose in mmol/L 
divided by 22.5 
Bone Biomarkers 
     Osteocalcin 





     Body Mass Index (BMI) 
     BMI Percentile 
     Waist Circumference 
 
Mass in kg divided by Height in Meters2 
CDC BMI Standards for Children 
Cm 
Psychosocial Health 
     Quality of Life 
     Self-Concept 
     Self-Esteem 
     Depression 
 
Peds QL 4.0 
Piers-Harris 2 Self-Concept Scale 
Coopersmith Self-Esteem Inventory 
Children’s Depression Inventory 
*Klinefelter Syndrome Phenotype Index is a summed total value that reflects the 
presence or absence of physical traits. CDC = Centers for Disease Control 









Table 3.3 Summary of Study Variables: Aim II 
Variables Measurement 
Testosterone (Serum ) 
ng/dl 
Bone Mineral Density 
     Anterior/Posterior (AP) Spine Z Score 
     Total Bone Mineral Density Z Score 
 




     Body Mass Index 
     BMI Percentile 
     BMI Z Score 
     % Body Fat 
 
Mass in kg divided by Height in Meters2 




KS Physical Characteristics 
The KS physical phenotype as reported in adult males includes tall stature with 
eunuchoid proportions (lower body segment longer than upper body segment), 
gynecomastia, light to absent facial or body hair, small testes, small phallus and 
decreased upper body muscle mass (Bojesen & Gravholt, 2007). A variety of other 
features have also been observed including hypertelorism, high-arched palate, wide arm 
span, elbow dysplasia, skeletal abnormalities, clinodactyly and hand tremor (Baughman, 
1969; Kamischke, et al., 2003). 
 To characterize the phenotype features of KS in peripubertal boys, the 
investigator collected physical observations and anthropometric measures during a 
physical examination. To reduce the possibility of investigator bias in the collection of 
data from the physical exam, a second health care provider randomly spot-checked 
measurements and observations in 10% of the boys. A composite score of clinical 




  Height was measured to the nearest 0.1 cm in a standing position with either a 
Seca fixed wall-mounted or a portable Charder HM200P clinical stadiometer.  The 
subjects were measured wearing a hospital gown with shoes and socks removed. Subjects 
were positioned using the Frankfort Horizontal Plane; a horizontal plane represented in 
profile by a line between the lowest point on the margin of the orbit and the highest point 
on the margin of the auditory meatus. Height was measured three times. The average of 
the height measurements was used (Hall, 1995).  Reliability between the wall-mount and 
the portable stadiometers was measured by comparing heights in cm taken from 30 adult 
volunteers. 
        Weight was measured to the nearest 0.1 kg on a calibrated RLS clinical digital scale 
(measurements at CUMC) or a calibrated portable UC-321 digital scale (off-site 
measurements). Weight was measured with patient wearing a hospital gown with shoes 
and socks removed. Weight was measured successively three times on the same scale and 
the average of the weights was used (Hall, 1995).  Reliability between the clinical scale 
and the portable scale was measured by comparing weight in kg taken from 30 adult 
volunteers. 
Waist circumference (WC) was measured using a non-stretchable measuring tape 
according to the National Health and Nutrition Survey III (Fernandez, Redden, 
Pietrobelli, & Allison) guidelines. Subjects were measured standing with legs together 
and arms at their sides with palms facing inward. The midpoint of the inferior margin 
(lowest point) of the last rib, and the crest of the ilium was located.  The subject was 
asked to exhale gently. WC was measured at just above the uppermost lateral border of 
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the right ilium to the nearest 1 mm. WC was measured successively 3 times by the same 
examiner using the same measuring tape. The average measurement was recorded. 
(NHANES III Anthropometric Guidelines accessed 2009). WC was compared to 
NHANES III norms for boys according to age and ethnicity (Fernandez et al 2004). 
Abnormal WC was defined as values ≥ 90th percentile. 
BMI was calculated for height and age using the Centers for Disease Control 
(CDC) BMI for Children online calculator (CDC, 2009).  BMI percentiles were used to 
characterize overweight. A BMI value greater than the 85th percentile was used to 
determine overweight status. 
Upper to lower body segment ratio was measured with the subject in a standing 
position.  The top of the pubic bone was palpated.  The lower segment was measured 
from the top of the middle part of the public bone to the sole of the foot to the nearest 0.1 
cm.  The lower segment was subtracted from the total height to obtain the upper body 
segment measurement. The upper to lower segment ratio was calculated by dividing 
upper body segment by the lower body segment. Upper to lower segment ratios less than 
1.0 were considered abnormal (Hall, 1995) 
Arm Span was measured to the nearest 0.1 cm with the subject standing against a 
flat wall with arms outstretched to create a 90-degree angle with the torso.  The distance 
between the tips of the right and left middle fingers were measured in centimeters using a 
non-stretchable measuring tape.  Measurements were taken 3 times. The average of the 




Hypertelorism (abnormally wide distance between the inner canthus of each eye) 
was determined by measurement of the inner canthal distance using a disposable plastic 
ruler (Hall et al 1995). Inner canthal distance ≥ 2 SD was determined to be classified as 
hypertelorism (Zeger et al 2008, (Hall, 1995). 
Sexual maturation was assessed by clinical observation of the presence and 
distribution of pubic hair, stretched phallic length, appearance of scrotum  and staged 1 to 
5 according to the guidelines of Tanner (Tanner, 1975). 
Stretched phallic length was measured according to the guidelines of Lee et al. 
(1980). A disposable wooden tongue blade was pressed against the pubic ramus 
depressing the suprapubic fat pad as completely as possible. Grasping the glans between 
a thumb and forefinger the phallus was stretched.  Phallic length was marked with a pen 
on the tongue blade.  The tongue blade marking was then measured on a clear plastic mm 
ruler.  Phallic length measurement to the nearest 1 mm was compared to the normal size 
range for chronological age using the normative measurements for age established by 
Schonfeld & Beebe (1942). 
Testicular volume was measured using Prader Orchidometer Beads. With the 
subject lying supine, testes were manually palpated and compared for size according to 
the technique of Prader using Prader Orchidometer Beads. If testes were of different 
sizes, the average of the 2 testes were taken.(Hall, 1995). 
Gynecomastia was assessed using Tanner staging and bimanual palpation to 
distinguish between presence or absence of lipomastia or glandular tissue (Johnson & 
Murad, 2009).  
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Skeletal Abnormalities.  Subjects were assessed for the presence of elbow 
dysplasia (Ross, et al.), scoliosis and pectus deformities. 
Clinodactyly was assessed by observation of the angle of the fifth finger distal 
interphalangeal joint (Zeger, et al.). 
 Hand tremor.  Examining the subject’s hands at rest in their lap while seated 
assessed involuntary tremor. Intention tremor was assessed by visual observation as 
subject reached for an object such as a pen from the hand of the examiner (Baughman, 
1969). 
High Arched Palate was assessed by observation of the height of the palatal vault 
in relation to the alveolar ridge. When maximum palate height was greater than twice the 
height of the teeth, it was considered to be abnormally high (Hall, 1995).  
 
Klinefelter Syndrome Phenotype  (KSPHE)  
 To operationalize the characterization of physical phenotype, a Klinefelter 
Syndrome Phenotype (KSPHE) Score was created using anthropometric measures and 
clinical observations. The KSPHE tool was modeled after the Mainz Severity Score 
Index, an instrument for quantifying the Anderson-Fabry disease phenotype (Parini, et 
al., 2008a; Whybra, et al., 2004). Other severity score indices for conditions such as 
Gaucher Disease (Di Roco M., 2008) and splenic function in children with sickle cell 





 The KSPHE score is a summed total value that reflects the presence (score = 1) 
or absence (score = 0) of each KS trait.  The total score ranges from 0-13 with higher 
scores representing the presence of more KS physical features. Table 3.4 illustrates the 
scoring criteria for determining the KSPHE score.  
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Table 3.4. The Klinefelter Physical Phenotype (KSPHE) Scoring Criteria 
Variable Score 
Tall Stature 
(CDC Growth Charts) 
0 = < 90th percentile 
 
1 = ≥ 90th percentile 
Eunuchoid body 
proportion Upper to 
lower height ratio 
 (Nwosu & Lee, 2008) 
0 = non-eunuchoid stature  
(ratio ≥.95) 
 
1 = eunuchoid stature  
(ratio ≤ .94) 
Arm Span 
(Bojesen & Gravholt, 2007) 
0 = normal range (arm span ≤ 
4.9 cm of height) 
 
1 = abnormal (arm span 
exceeding height by 5 cm) 
Waist Circumference 
(Fernandez, et al., 2004) 
0 = <90th percentile 
 
1 = ≥ 90th percentile 
Body Mass index 
(CDC Guidelines) 
0 = ≤ 85th percentile 
 
1 = > 85th percentile 
Gynecomastia 
(Johnson & Murad, 2009) 
0 = Absent 
 







(Rundle A.T. & Sylvester, 
1962) 
0 = normal range for Tanner 
Stage (TS)  
       TS I:     2 mL   
       TS II:    3 mL   
       TS III: 10 mL 
       TS IV: 20 mL 
       TS V:  29 mL 
1= less than expected volume 
for TS   
      TS I:     < 2 mL  
      TS II:    < 3 mL  
      TS III:  < 10 mL 
      TS IV:  < 20 mL 








0 = normal range for age  
 
1 = short for age (minus 1 
Std Deviation)  
        8-12   Years   ≤4.9cm 
         13     Years   ≤6.1 cm 
         14     Years   ≤6.6 cm 
         15     Years   ≤9.1 
         16- Adult      ≤ 10.8 cm 
Bone or skeletal 
abnormalities 
(Ross, et al., 2005) 
0 = not present 
 
1 = present 
High-arched palate 
(Hall, 1995) 
0 = not present 
 
1 = present 
Clinodactyly 
(Hall, 1995) 
0 = not present 
 
1 = present 
Hand Tremor 
(Baughman, 1969) 
0 = not present 
 
1 = present 
Hypertelorism 
(Hall, 1995) 
0 = not present 
 
1 = present 
   






A single serum sample of approximately 25 mL of whole blood was collected 
from each fasting participant prior to 10 AM for measurement of reproductive hormones, 
cardiometabolic and bone biomarkers. 
Reproductive Hormones 
 
        Measurement of reproductive hormones (total testosterone, free testosterone, % free 
testosterone, follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol, 
sex hormone binding globulin and dehydroepiandrosterone sulfate (DHEAS) was 
collected to assess functional gonadal status. Esoterix Laboratory in Calabasas, CA, a 
subsidiary of LabCorp, specializing in pediatric neuroendocrine testing, performed all 
hormonal assays. Details regarding technique, sensitivities and coefficients of hormonal 


























Table 3.5 Reproductive Hormone Assay Techniques with Sensitivities and Coefficients 
of Variation by Esoterix Laboratory 2010 
 
Test Technique* Minimum 
Detection 
 







3 ng/dL.  Intra-assay precision shows 17.3% 
(Wang, et al.) at 2.76 ng/dL to 1.72% 
(Wang, et al.) at 544.67 ng/dL.  Inter-
assay precision shows 14.8 % (Wang, 
et al.) at 3.30 ng/dL to 5.0% (Wang, 









Intra-assay precision is 9.4%  (CV) at 
0.53% (free T) to 8.9% (CV) at 




ECL  Lower limit of 
detection: 
0.001mIU/mL 
Lower limit of 
quantification: 




Inter-assay precision shows 7.8% 
(Wang, et al.) at 0.566 mIU/mL to 




ECL 0.017 mIU/mL  Inter-assay CV precision ranged from 








 0.1 ng/dL.  
 
Intra-assay precision is 2.27 %, 
coefficient of variation (Wang, et al.) 
at 1.06 ng/dL to 3.23% (Wang, et al.) 
at 28.57 ng/dL. The inter-assay 
precision is 4.36% (Wang, et al.) at 





IRMA 10 nmol/L. 
 
Intra-assay precision is 4.5% (CV) at 
12.6 nmol/L to 4.7% (CV) at 166.7 
nmol/L. 
DHEAS ECL Sensitivity was 
0.05 umol/L.  
Interassay coefficient of variation 
ranged from 8.1-15%. 
Serum sample were used for each analyte. 
*Assay Techniques: 
ECL Electrochemiluminescent                        MS/MS: Tandem mass spectrometry 
IRMA: Immunoradiometric assay                  HPLC: High-pressure liquid chromatography 




Cardiometabolic Biomarkers and Bone Biomarkers: 
 
       The following cardiometabolic and bone measures were assessed: lipids (total 
cholesterol, low density lipoproteins (LDL) high density lipoproteins (HDL), 
triglycerides), glucose, insulin, osteocalcin and 25, hydroxy vitamin D. All blood samples 
for serum and plasma determinations were collected with subjects in a fasting state. 
LabCorp, the parent company of Esoterix, analyzed all cardiometabolic biomarkers. 
Table 3.6 provides detail regarding normative ranges for children and methods of 
measurement by LabCorp. 
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Table 3.6 Cardiometabolic and Bone Biomarkers 
Cardiometabolic Biomarkers and 






Lipids (In Children ≤ 18 years) 
Total Cholesterol 
    Desirable <170 High >200 
HDL 
     Desirable = 45   
LDL 
     Desirable <110 High >130 
Triglycerides (in male children) 
       6-11  years 31-108 mg/dL 
     12-15 years 36-138 mg/dL 




Serum: measured calorimetrically 




Child:                3.3-5.6 mmol/L 
  





Plasma: hexokinase method 
(Glucose/HK; Roche Molecular 
Biochemicals, Werk Penzberg, Federal 
Republic of Germany.  Assay 
sensitivity is 1 mg/dL. Intra and inter 




0-8 years        0-13 µU/ml 
 
>8 years         0-17 µU/mL 
µU/mL Plasma: as solid phase I- RIA (coat-a-
count; DPC, Los Angeles, Ca,) 
Sensitivity is 7.2 pmol/L. Intra and 
inter-assay CV are from minimum 5% 
to maximum of 15% 
Hemoglobin A1c  > 5.6 % Percent Fraction of glycated hemoglobin by 
HPLC/MS 




The product of glucose in mmol/L and 
insulin divided by 22.5 (Mathews, 
1985) 
Scores range from 0-15 with higher 
scores indicating greater insulin 
resistance. 
Osteocalcin  
Normal Range (in male children) 
                  36-105 ng/mL 
(Yang & Grey, 2006) 
ng/mL Serum: by ELISA 
Vitamin D, 25 hydroxy  
     Desirable Range: 10-55 ng/ml 
ng/mL Serum: by ICMA 
RIA- Radioimmunoassay. HPLC/LC-High pressure liquid chromatography mass spectrometry.. 





Handling and Processing of Blood Materials 
For children evaluated off-site, specimens were collected at local LabCorp 
laboratories. Reproductive hormonal assays were labeled and shipped according to 
company protocol in compliance with the US Department of Transportation (DOT) and 
the International Air Transport Association (IATA). Specimens were shipped to Esoterix 
Laboratories for processing. 
For children evaluated at the Pediatric Research Unit at CUMC, specimen were 
collected, frozen and placed in a calibrated and temperature-monitored research freezer 
located in the main laboratory at the Morgan Stanley Children’s Hospital. Prior to 
shipping, each tube was wrapped in absorbent material and placed in a watertight 
cellophane bag.  Cellophane bags were wrapped with absorbent material and placed in a 
styrofoam container that contained 0.5 kg of dry ice pellets. An itemized list of contents 
was placed in the styrofoam container. Absorbent material was placed between the dry 
ice and the specimens. The styrofoam container was closed with a single length of tape to 
allow the container to dissipate carbon dioxide from the ice.  The styrofoam box was 
labeled, “Biological Substance, Category B” and “UN1845 Dry Ice Net weight = 0.5 kg”. 
The styrofoam container was then placed in a larger cardboard box lined with absorbent 
materials.  The outer box was then taped and labeled as designated above. A courier from 
LabCorp picked up the package and transported it to the local LabCorp site. Reproductive 
hormonal assays were then shipped from the local LabCorp to the Esoterix laboratory 




Psychosocial Health and Well-Being 
     The instruments used to measure psychosocial health and well-being are presented in 
Table 3.7. To minimize systematic response fatigue bias in survey responses due to 
multiple survey questions, all psychosocial instruments were administered in random 
order to participants (B. Choi & Pak, 2005).  A number from 1-4 was randomly drawn 
from an envelope prior to the study visit to determine the order of questionnaires. All 
instruments are self-administered questionnaires. Each has been validated for use with 
children and has been used in many child development studies.  Further description of 
each measure is provided below. 
Table 3.7 Psychosocial Health & Well-Being Measures 
 
Concept Instrument Reliability Number of 
Items 










    











from0 .80 to 
0.86 
 














































Quality of Life 
The Peds QL 4.0 ® Generic Core Scale is a validated 23 item questionnaire that 
covers the domains of physical, emotional, social and school functioning. The version for 
Children (ages 8-12 years) and the Teen version (ages 13-18) were used for this study. 
The Child and Teen versions are virtually identical except for the social subscale (How I 
get Along with Others), where the word “kids” is replaced by the word “teens”. 
Reliability between the Child and Teen Versions is 0.96. This questionnaire takes 
approximately 10 minutes to complete. A five-point response scale is used for both the 
child and teen self-report (0 = never a problem, 1 = almost never, 2 = sometimes, 3 = 
often, 4 = almost always) and is scored exactly the same.  All items are reverse-scored (0 
=100, 1 = 75, 2 = 50, 3 = 25, and 4 = 0) and converted to a 100-point scale with higher 
scores indicating better quality of life. The questionnaire takes approximately 10 minutes 
to complete. This instrument shows high internal consistency with overall Cronbach 
alpha of 0.91 (Varni, Seid, & Kurtin, 2001) and subscale scores as follows: Physical 
Functioning (0.83), Emotional Functioning (.81), Social Functioning (.82), and School 
Functioning (.89). The Peds QL 4.0 has been validated for several healthy populations 
(Varni, Seid, Knight, Uzark, & Szer, 2002; Varni, et al., 2001; Varni, Seid, & Rode, 
1999) and those with chronic conditions e.g. cancer, diabetes, and overweight and 
(Goldstein, et al., 2006; Schwimmer, Burwinkle, & Varni, 2003; Uzark, et al., 2008; 
Varni, Burwinkle, & Katz, 2004; Varni, Burwinkle, Rapoff, Kamps, & Olson, 2004; 
Varni, et al., 2006; Varni, Limbers, & Burwinkle, 2007; Varni, Limbers, Burwinkle, 
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Bryant, & Wilson, 2008). In general populations of school children, the cut-point 
indicating good quality of life is 80 (Varni, et al., 2001) .  
 
Self-concept 
 The Piers-Harris 2 Self-Concept Scale is a child self-report measure of self-
concept designed for children between the ages of 7 and 18 years.  It consists of 80 
statements that the child rates as “yes” or “no” based upon how they feel about 
themselves. There are six domain scales for the Piers-Harris 2 including: behavioral 
adjustment, intellectual and school, physical attributes, freedom from anxiety, popularity 
and happiness.  “Yes” or “No” answers are scored according to algorithm and then are 
converted to standardized T scores with higher T scores indicating better self-concept. 
The Piers-Harris 2 Scale Interpretation Guide (Piers, 1984) reports that higher T scores 
indicate better self-concept for total scores and all 6 domain scales. T Scores above 59 are 
considered high, scores between 40 and 59 are considered average while scores below 40 
are considered to indicate low self-concept. The cut-point for low self-concept is a T 
score below 40 (Piers, 1984). 
The six subscales with internal consistency scores are as follows:  Total score 
(0.91), behavioral adjustment (0.81), intellectual and school status, (0.81), physical 
appearance and attributes (0.75), freedom from anxiety (0.81), popularity (0.74) and 
happiness and satisfaction (0.77) (Piers, 1984). This scale has been used widely in normal 
populations of school children, learning-disabled children and those with chronic 




The Coopersmith Self-Esteem Inventory (SEI) is a validated questionnaire used to 
measure self- esteem. For this study, the SEI School Short Form (KS boys 8 to 15 years) 
and the Coopersmith Inventory Adult scale (KS boys ≥16 years) was used. The SEI is 
non-gender specific. The School Short Form and the Adult Form are virtually identical 
with word “kids” replaced by “people” and “parents” replaced by “family” in the adult 
form. The total score correlation between the School Short Form and the longer 80 item 
School Form is 0.86. The SEI takes about 5 minutes to complete. Both the school short 
form and the adult form consist of 25 items. The responses are recorded by answering 
“like me” or “not like me”.  Questions are asked sometimes in the positive and sometimes 
in the negative. One point is scored for each question answered correctly according to the 
scoring algorithm. The raw score is multiplied by 4 to arrive at the total score.  Scores 
may range of 0 to 100 with higher scores indicating higher self-esteem. The Coopersmith 
Inventory Adult form consists of the same items as the School Short Form modified to 
make them more meaningful to persons whose lives are not as closely bound to parents 
and school as the School Short Form. The total score correlation between the School 
Form and the Adult Form exceeds 0.80 (Coopersmith, 2002). The SEI has been used with 
cognitively impaired pediatric populations (Chui, 1990; Cline, 1975), adolescents with 
chronic fatigue syndrome (Denborough, 2003),  adolescents with cancer (Ritchie, 2001) 
and adults with mild intellectual disability (King, 1999). The SEI has been normed 
extensively in populations of American school children and in adults (Coopersmith, 




The Children’s Depression Inventory (CDI) is a validated screening tool designed 
to assess depression in children between the ages of 8 and 17 years of age by clinicians 
and researchers.  The CDI has been used in many types of research studies including 
cross-sectional epidemiological, community-based studies, studies of at-risk juvenile 
populations and treatment outcome studies (Kovacs, 1980).  
The CDI contains 28 items, each of which consists of three statements. For each 
item, the individual is asked to select the statement that best describes his or her feelings 
for the past two weeks. The CDI contains 5 subscales that assess negative mood, 
interpersonal problems, ineffectiveness, anhedonia (the inability to experience pleasure) 
and negative self-esteem.  The test is scored according to a scoring algorithm that 
accounts for questions asked in a negative or positive direction. Raw scores for the total 
and each subscale are then converted to standardized T scores according to age and 
gender. The test takes from 5- 10 minutes to administer with reported internal consistency 
for this tool ranging between 0 .81 to 0.89 and the test-retest coefficients range from 0.84 
to 0.83 (time interval two-three weeks) (Kovacs, 1980). The CDI has been used in 
healthy populations of children (Chang, Zauszniewski, Heinzer, Musil, & Tsai, 2007; 
Kovacs, 1980), and those with chronic health conditions (Buelow, et al., 2003; Cortese, et 
al., 2009; Nelson, Politano, Finch, Wendel, & Mayhall, 1987).  A cutoff T score of 54 
suggests high risk for depression in clinical samples in which a higher depression 
incidence is expected (Kovacs, 1980).  
 For the present study, if a child had a T score of 58 or greater on the depression 
scale and responded affirmatively to the statement, “I want to kill myself”, the child was 
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immediately referred for a mental health evaluation, according to the approved IRB 
protocol. 
Adolescents with KS are generally described as being less mature and at higher 
risk for depression compared to healthy peers (Bender, et al., 1993; Temple & Sanfilippo, 
2003; van Rijn, et al., 2008). While this screening tool targets children in the age range of 
8-17 years, in this study, 4 KS subjects who were 18 years old at the time of the study 
were also screened with this tool.  
Data Analysis Plan 
All data were entered into Excel spreadsheets. Unique spreadsheets were 
developed for demographic, clinical measurement, laboratory, psychosocial and bone 
mineral density data. Prior to analyses, each database was cleaned and double-checked 
for data entry accuracy by the investigator.  All data were exported from the Excel 
databases and analyzed using SAS software Version 9.2 of the SAS System for Unix 
(2008) Cary, NC. The presence of outlier data was visually explored using scatter 
plots. Data were examined for normality of distribution using the Shapiro-Wilk test.  
Where data were not normally distributed, a non-parametric statistical test was used for 
comparison and correlational analysis.  Missing data were managed by removing the 
subject from the specific analysis.  Initial analysis of each variable included frequencies, 
means and measures of central tendency.  For each psychosocial measure, a reliability 
estimate using Cronbach Alpha for testing internal consistency between items was 
performed.    
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An exploratory data analysis was performed to first provide graphic 
representations (e.g. scatter plots) of relationships between variables. 
 Univariate linear regression models were used to examine relationships between 
physical, psychosocial and laboratory data. The variable testosterone was explored as a 
continuous variable (ng/dl) and as a categorical variable (Low Testosterone versus 
Normal Testosterone). Low testosterone was defined as lowest quartile of normal range 
according to Tanner stage of sexual maturation (Chandler, 2011; Zeger, et al., 2008). 
 For each hypothesis, an alpha of 0.05 was employed to determine level of 
significance.  Bonferroni criteria were applied to adjust p-values when multiple subscales 
were analyzed in the psychosocial univariate regression analysis. In cases where the 
results of simple linear regression demonstrated a statistically significant relationship 
between the dependent and independent variable of interest, the relationship was further 
tested in a multivariate regression model controlling for age and prior or current 
treatment with testosterone. 
Descriptive statistics and univariate linear regression were used to describe body 
fat and bone mineral density Z scores of subjects in the retrospective chart review. Table 




Table 3.8 Summary of Data Analysis Plan 
Aims & Hypotheses 
 
Analysis Plan 
Aim 1: to examine the association between KS physical 
phenotype, reproductive and metabolic hormones and 
psychosocial health characteristics. 
Means with SD, 
frequencies and 
percentages, chi square 
and Fisher’s Exact 
Hypothesis 1.1: Physical phenotype as measured by KS 
physical phenotype index score is inversely related to 
psychosocial well-being (quality of life, self-esteem, self-





Hypothesis 1.2: Testosterone levels are positively associated 
with scores for quality of life, self-esteem and self-concept 





Hypothesis 1.3: Physical phenotype as measured by a KS 






Hypothesis 1.4: Testosterone levels are negatively associated 




Aim II of this study was to compare body fat and bone mass 
in a sample of KS boys to normative data from boys 
unaffected by KS. 
 
 
Means with SD, 
frequencies and 
percentages 
Hypothesis 2.1    Boys with KS have a higher proportion of 
body fat as measured by Dual Energy Xray Absorptiometry 






Hypothesis 2.2     Boys with KS have lower bone mass as 











The following variables were collected and considered as sources of possible 
confound:  parent educational level, participant age, participant knowledge of diagnosis, 
age at diagnosis, race/ethnicity, level of pubertal development and use of hormone 
(testosterone) replacement therapy. The small sample size limited inclusion of all 
potential confounders in multivariate models; however, we considered age the most 





This chapter describes the results of subject recruitment for this study and 
organizes results according to aim. Results for Aim I give a description of the 
demographic characteristics from the cross-sectional study, the physical and clinical 
history information, anthropometric data, characterization of phenotype by the KSPHE 
score, reproductive hormone, cardiometabolic and bone biomarker data and results of the 
psychosocial health measurements. Hypothesis testing using univariate and multivariate 
linear regression for the 4 hypotheses associated with Aim I follow. Results for Aim II 
are then reported, first with demographic description of the sample of the retrospective 
review study. Results are reported as descriptive statistics followed by an examination of 
the relationships between age body fat and testosterone and bone mineral density. 
 
Recruitment Response 
       Recruitment took place between August of 2009 and August of 2010. Traditional 
modes of recruitment, such as brochure dissemination, letters to physicians and family 
contacts within the pediatric endocrine specialty practice at CUMC were successful in 
only 9%  (n = 4) of the sample required for the study. Recruitment efforts were expanded 
to national and regional KS support groups, study website, professional recruitment 
matching service, social network advertisement via Facebook™ and monthly 






After IRB approval, one hundred twelve families were approached regarding 
participation in the cross-sectional study (Aim I). Seventeen families chose not to 
participate due to concerns about disclosure of diagnosis to the child.  Fifty-one families 
declined participation due to travel and other cost constraints.  The remaining 43 
candidates chose to participate. No subjects withdrew from the study or failed to 
complete all study components (physical examination, laboratory assessment, completion 
of study questionnaires). In addition, 20 outpatient medical records of patients with KS 
met the eligibility criteria for inclusion in the bone mineral density component of the 
study (Aim II). 
 
Aim I. To describe physical phenotype, reproductive hormones, cardiometabolic 
biomarkers and psychosocial parameters in boys with Klinefelter Syndrome (KS). 
Demographic Characteristics  
 
A summary of demographic data is presented in Table 4.1. The majority of 
subjects were Caucasian (86%) and from households where parents were college-
educated (95%) and lived in the northeast US (72.1).  The mean age of subjects was 12.5  
± 3.1 years; on average parents were in their mid-thirties (maternal age 34.2 ± 5.4; 
paternal age 36.1 ± 6.7 years at the time of the child’s birth.  Approximately 91% of the 
boys in the sample functioned at an appropriate academic grade level for age, although 
some level of supplemental educational was reported in over half of cases. Rehabilitation 
therapies were common in the sample with the most frequent type seen as speech and 
language therapy in 76.7% of the sample. 
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Table 4.1 Demographic Characteristics of the Sample 
 
Characteristic Total (N= 43) 
Mean ± SD (Range) 
Child’s Age (Years) 
      
12.5 ±3.1 (8-18) 
Maternal Age at Child’s Birth 
        
34.2  ± 5.4 (21-38) 
Paternal Age at Child’s Birth 
        
36.1 ± 6 (19-52) 
  
Race                 Frequency (%) 
     Caucasian 37 (86.0) 
     African American 1 (2.3) 
     Hispanic 4 (9.3) 
     Asian 1 (2.3) 
  
Place of Residency  
     Eastern US 31 (72.1) 
     Central US 9 (20.9) 
     Western US 1 (2.3) 
     International 2 (4.65) 
  
Parental Highest Education  
     High School Diploma 2 (4.7) 
     Bachelor’s Degree 14 (32.3) 
     Master’s Degree 18 (41.9) 
     Doctoral Degree 9 (20.9) 
  
Child’s Education  
    Grade Level for Age 39 (90.7) 
    Held back a grade                          4 (9.3) 
    Special Education Program 7 (16.3) 
    Individual Education Plan 24 (55.8) 
  
Childhood Adjunctive Therapies 
    Speech & Language 33 (76.7) 
    Physical 18 (41.9) 
    Occupational 25 (58.1) 
    Psychiatric 16 (37.1) 







Clinical Histories & KS Karyotypes 
 
Clinical characteristics and KS karyotype are summarized in Table 4.2. Non-
mosaic 47, XXY was the most common karyotype with over half of the sample (65.1%) 
having been diagnosed prenatally due to maternal age. Nearly Two-thirds were aware of 
the sample was aware of their diagnosis of 47XXY (62.8%).  
Approximately half  (n = 22; 51%) of the sample had been treated with 
testosterone during infancy, childhood or adolescence. The most common form of 
treatment was by injection (23.3%). 
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Table 4.2 Clinical History* and KS Features of the Sample  
 
Characteristic Total 
N = 43 
Frequency (%) 
Klinefelter Karyotype 
        47 XXY non-mosaic 




Time of Diagnosis 
        Pre-natal (Amniocentesis) 




Reason for Diagnosis 
         Maternal Age 
         Developmental Delay 
         Growth Problems 
         Genital Abnormalities 
         Speech & Language 
         Behavior 
         Hand Tremors 
 
28 (65.1) 






Child’s Knowledge of Diagnosis 
           Yes 




History of Testosterone Therapy 
 
 Infant Treatment Only             
 
        Childhood/Adolescent 
        Injection 
        Gel 
        Patch 
        Oral (Oxandrolone) 
Mixed History 












Results presented as frequencies with percentages. * Reported by parents 
 
 
Although sexual development of boys in the sample spanned all Tanner stage 
levels, the majority of the sample was pubertal (Tanner stage 2-5; 62.8%) or in pre- 
puberty (Tanner stage 1; 37.2%). The summary of mean ages grouped by pubertal status 
(pre-pubertal versus pubertal), Tanner stage, and testosterone treatment status are shown 
in Table 4.3.  
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Table 4.3 Mean Ages of Sample According to Pubertal Status, Tanner Stage and 
Testosterone Treatment Exposure  
 
Age in Years Total 
N = 43 
Mean ± SD 
Total 
N = 43 
Age Range 
Total 
N = 43 
Frequency (%) 
Total Sample 12.5 ± 3.1 8-18 43 (100) 
 Age by Pubertal Category  
        Pre-pubertal 










 Age by Tanner Stage 
        Tanner stage 1 
        Tanner stage 2 
        Tanner stage 3 
        Tanner stage 4 
        Tanner stage 5 
 
9.5 ± 1.3 
12.2 ± 1.2 
13.5 ± 1.3 
15.1 ± 1.8 











    8 (18.6) 
    5 (11.6) 
 Age by Testosterone Treatment  
        No Treatment Exposure 
        Ever Been Treated 
 








Age by Tanner Stage and 
Treatment Exposure 
         Tanner stage 1 
                 Untreated 
                 Treated 
        Tanner stage 2 
                Untreated 
                 Treated 
        Tanner stage 3 
                Untreated 
                 Treated 
         Tanner stage 4 
                 Untreated 
                 Treated 
          Tanner stage 5 
                 Untreated 




9.7 ± 1.3 
9.0 ± 1.0 
 
12.1 ± 1.1 
12.5 ± 2.1 
 
13.0 ± 0 
13.6± 1.5 
 
13.0 ± 0 
 15.4 ±1.7 
 
N/A 






















5  (11.6) 
 
8 (18.6) 






  7 (16.3) 
 
               0 (0) 
  5 (11.6) 
 Age by Pubertal Stage and 
Treatment Exposure 
         Prepubertal  
                 Untreated 
                 Treated 
Pubertal 
                Untreated 




9.7 ± 1.3 
9.0 ± 1.0 
 
12.3 ± 1.0 













5  (11.6) 
 
10 (23.3) 
 17  (39.5) 





Clinical History: Physical Health Problems 
Physical health problems as reported by parents are summarized in Table 4.4. 
Respiratory problems (37.2%) were the most frequently reported health issue. Parents 
reported that their sons had reactive airway problems during upper respiratory infections 
that often lead to pneumonia. One boy in the sample had been diagnosed with asthma. 
Parents also reported visual problems (30.2%) such as myopia and astigmatism. Vision 
problems were more likely in boys reaching puberty compared to pre-pubertal boys 
(44.4% versus 6.3% p = 0.0143). 
Other less frequently reported health problems included bone and joint disorders, 
gastrointestinal issues, genitourinary conditions, immune and skin problems. Bone and 
joint disorders including scoliosis, thoracic bone deformity and joint laxity were reported 
in 9 boys (20.9%). Gastrointestinal problems such as reflux, frequent indigestion and 
diarrhea were noted in 8 boys (20.9%).  Genitourinary issues such as hypospadia, 
undescended testis, microphallus and frequent urinary tract infections were noted in 6 of 
the boys (13.9%). Three parents (6.9%) reported immune problems; one boy had a 
history of severe food allergy and two had a histories of frequent infections. Acne and 
mild rashes were reported in 9 boys (20.9%).  
 
Clinical History: Psychosocial Health Problems 
Language, learning and behavioral problems were commonly reported as shown 
in Table 4.4. The most frequently reported problems were learning issues (69.8%), 
speech and language difficulties (67.4%) and social interaction problems such as 
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difficulty in making and keeping friends (61.9%).  Attention deficit hyperactivity 
disorder was reported by approximately by 38.1% of the sample; six (14.6% boys had 
had received a diagnosis of autism spectrum disorder.  Eight boys (19.1%) had histories 
of psychiatric problems due to depression. One of the boys diagnosed with depression 
had a co-occurring diagnosis of psychosexual aggression disorder. Parents of boys in the 
pubertal group more frequently reported problems in the areas of behavior (66.7% versus 
31.3% p = 0.0316), learning (85.2% versus 43.8% p = 0.0067) and psychiatric difficulties 
(33.3% versus 0%  p = 0.0161). 
Table 4.4 Frequencies of Physical and Psychosocial Health Problems † of the Study 

















      p-value* 
Physical Problems†     
     Vision  13 (30.2) 1 (6.3)    12 (44.4) 0.0143 
     Hearing  3  (6.9) 1 (6.3)  2 (7.4) 1.0 
     Respiratory  16  (37.2)   9 (56.3)     7 (25.9) 0.0589 
     Gastrointestinal    9  (20.9)   2 (12.5)      7 (25.9) 0.4455 
     Immune 3 (6.9) 1 (6.3)           2 (7.1) 1.0 
     Skeletal     9  (20.9) 2 (12.5)    7 (25.9)  0.4455 
     Skin   9 (20.9) 3 (18.8)    6 (22.2)  1.0 
     Genitourinary   6 (13.9) 2 (12.5)    4 (14.8) 1.0 
     
Psychosocial Problems†    
     
     Speech & 
Language 
 29 (67.4) 9 (56.3)  20 (74.1) 0.3161 
     Behavior  23 (53.5) 5 (31.3)  18 (66.7) 0.0316 
     Learning 30 (69.8) 7 (43.8)   23 (85.2)    0.0067 
     ADHD  16 (37.2)   4 (25.0)  12 (44.4) 0.3283 
     Autism/Asperger   6 (14.6) 1 (6.3) 5 (18.5) 0.3805 
     Social Interaction 27 (62.8)   7 (43.8)     20 (74.1)   0.0589 
     Psychiatric   9 (20.9) 0     9 (33.3) 0.0161 





KS Physical Measurements 
Table 4.5 presents the anthropometric features of the sample.   As expected, 
anthropometric measurements demonstrated that boys in the pubertal group were 
significantly taller, had longer arms, larger waist circumference, and more sexually 
mature compared to pre-pubertal boys.  There were no differences between the groups for 
BMI percentile, BMI Z score or inner canthal distance. A high proportion of boys 
demonstrated KS-related clinical features: clinodactyly (53.5%) high-arched palate 
(41.9%) and hand tremor (34.9%).  Boys in the pubertal group had a higher incidence of 











Mean ± SD 
 Pre-pubertal 
 
N = 16 
Mean ± SD 
Pubertal 
 
N = 27 
Mean ± SD 
 
p-value 
     
Mean Age in Years 
       (Range) 




14.3 ± 2.4 
(11-18) 
<0.0001 
     
Height (cm) 160.2 ± 18.6 142.9 ± 10.5 170.5 ± 14.4 <0.0001 
Upper Segment Height (cm) 80.7 ± 9.3 72.9 ± 5.2 85.8 ± 7.6 <0.0001 
Lower Segment Height (cm) 79.4 ± 10.4   70.1 ± 6.6 85.3 ± 7.7 <0.0001 
Arm Span (cm) 160.9 ± 19.8 142.1 ± 10.4 172.0 ± 14.9 <0.0001 
Weight (kg) 59 ± 28.4 37.4 ± 11.7  71.9 ± 27.6 <0.0001 
BMI 21.6 ± 6.8 18.0 ± 3.6  24.1 ± 7.3    0.0050 
BMI percent 64.2 ± 38.0 59.1 ± 36.9 67.1 ± 39.0 0.22 
BMI (Z) 0.43 ±1.6 0.13 ± 1.6 0.62 ± 1.7 0.23 
Waist Circumference (cm) 79.5 ± 21.0 65.8 ± 10.9  87.7 ± 21.4    0.0009 
Inner Canthal Distance (cm) 3.3 ± 0.4 3.3 ± 0.30  3.3 ± 0.45 0.97 
Testicular Volume (cc) 3.8 ± 2.8 1.53 ± 0.92 5.2 ± 2.6 <0.0001 
Phallic Length (cm) 7.1 ± 2.5 4.9 ± 1.0 8.4 ±2.1 <0.0001 
     
Note. Statistically significant values shown in boldface. Statistical analysis comparing mean 





Klinefelter Phenotype (KSPHE) Scores 
 Characteristics included as part of the KSPHE score ( 0 = not present, 1= present) 
are presented in Table 4.6. Approximately two-thirds (69.8%) of the sample 
demonstrated abnormal testicular volume for Tanner stage with or without eunuchoid 
body proportion (62.8%). Almost half (44.2%) of the sample was overweight and tall for 
age (37.2%).  Approximately one fourth of the sample demonstrated a waist 
circumference greater than the 90th percentile (25.8%) and arm span greater than height 
(23.3%). Phallic length was shorter than expected for age in 18 boys (37.2%). Other KS-
related features included fifth finger clinodactyly (53.5%), high arched palate (41.9%), 
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hand tremor (34.9%), gynecomastia (11.6%) and skeletal abnormalities (9.3%).  None 
met the criterion for hypertelorism. As expected, the pubertal group showed a greater 
proportion of boys with small testes for Tanner stage (p = 0.0427) compared to the pre-
pubertal group. Characteristics were summed to obtain the total KSPHE score. Mean 
KSPHE score for the total sample was 5.1 ± 1.9 with a range of 1-10. KSPHE scores 





Table 4.6 Frequencies of Subjects with Abnormal Physical Characteristics According to 
the Klinefelter Syndrome Phenotype (KSPHE) by Pubertal Status 
 
Physical Characteristics* Total 
 














     
Mean Age in Years 
          (Range) 









Klinefelter Syndrome Phenotype Score 
(KSPHE) †† 
 
KSPHE Score 5.1 ± 1.9 4.2 ± 0.98 5.6 ± 2.1 0.0115 
     
Tall Stature (Height > 90th 
percentile) 
16 (37.2) 6 (37.5) 10 (37.0) 1.0 
Eunuchoid Body Proportion 22 (51.2) 8 (50.0) 14 (51.9) 1.0 
BMI > 85th percentile 19 (44.2) 4 (25.0) 15 (55.6) 0.0644 
Arm Span > Height 10 (23.3) 2 (12.5) 8 (29.6) 0.2757 
Waist Circumference > 90th 
percentile 
11 (25.8) 2 (12.5) 9 (33.3) 0.1656 
Testicular Volume 
Abnormal for Tanner Stage 
30 (69.8) 8 (50.0) 22 (81.5) 0.0427 
Phallic Length Abnormal 
for Age 
16 (37.2) 7 (43.8) 9 (33.3) 0.5305 
Gynecomastia   5 (11.6) 0 5 (18.5) 0.1395 
Skeletal Abnormalities 4 (9.3) 0 4 (14.8) 0.2795 
High Arched Palate 18 (41.9) 3 (18.8) 15 (55.6) 0.0261 
Clinodactyly 23 (53.5) 8 (50.0) 15 (55.6) 0.7611 
Hand Tremor 15 (34.9) 4 (25.0) 11 (40.7) 0.3415 
Hypertelorism 0 0 0 N/A 
     
Note. Statistically significant values shown in boldface *Physical Characteristics used to calculate 
the KSPHE Score.  Statistical analysis by †Fisher’s Exact test. ‡ KSPHE score is the sum of the 







Reproductive Hormone Characteristics 
 Mean reproductive hormone levels are presented in Table 4.7. Serum testosterone 
levels ranged from 2.9 ng/dL to 1080 ng/dL with a mean of 269.8 ± 291.5ng/dL. As 
expected, significant differences between pubertal groups were observed for all 
reproductive hormone parameters, with the pubertal group showing higher values  
compared to the pre-pubertal group. While mean estradiol was higher in the pubertal boys 
(16.0 pg/mL ± 16.4 pg/mL versus 2.02 pg/mL ± 2.45 pg/mL), the mean 
estrogen/testosterone ratio was higher in the prepubertal boys compared to pubertal boys 
(15.7 ± 10.8 versus 4.5 ± 4.1). 
 In Table 4.8 the frequencies of subjects with abnormal hormone concentrations 
for Tanner stage are shown. Abnormal concentrations of reproductive hormones by 
Tanner stage were observed.  Serum testosterone was either below the normal range or in 
the low range in 7 boys (16.7%), values above the normal range levels were observed for 
LH in (n=21; 50%), FSH in (n=18; 42.9%). DHEAS values were low in 16 boys (38.1%). 
A higher proportion of boys in the pubertal group showed high concentration of FSH 
(66.7% versus 0; p = <0.001) and DHEAS (55.6% versus 6.7%; p = 0.0024). There were 
no differences between pubertal groups for the number of boys with abnormal findings 
for reproductive hormones, low testosterone, free testosterone, % free testosterone, 









Mean ± SD 
Prepubertal 
 
N = 15 
Mean ± SD 
          Pubertal 
 





     
Mean Age in Years 
        (Range) 
12.6± 1.3 




14.3 ± 2.4 
(11-18) 
<0.0001 
     
Testosterone (ng/dL) 269.8 ± 291.5 41.81 ± 78.7 396.43 ± 289.9 <0.0001 
Free Testosterone 
(pg/mL) 
46.8 ± 62.3 4.41 ± 5.3 65.9 ± 66.5 <0.0001 
% Free Testosterone 1.09 ±0.71 0.55 ± 0.33 1.4 ± 0.69  0.0004 
FSH  (mIU/mL) 16.3 ± 22.5 0.98 ± 0.71 24.3 ± 24.2  0.0003 
LH (mIU/mL) 8.6 ± 15.3 0.54 ± 0.98 13.0 ±17.7  0.0004 
Estradiol (pg/ml) 11.5 ± 15.0 2.07 ± 2.45 16.0 ±16.4 <0.0001 
SHBG (nmol/L) 58.1 ± 37.3 85.8 ± 33.9 37.7 ± 27.8  0.0004 




8.5 ± 8.9 
 
15.7  ± 10.8 
 
4.5 ± 4.1 
 
0.0006 
Note. Statistically significant values shown in boldface . *One subject was dropped from 
hormone analysis due to missing testosterone results. †Wilcoxon Rank Sum test. FSH-Follicle 
Stimulating Hormone LH-Luteinizing Hormone SHBG-Sex Hormone Binding Globulin DHEAS- 
Dehydroepiandrosterone Sulfate. Reproductive hormone Reference Ranges for Normal Males 





Table 4.8 Frequencies of Subjects with Abnormal Reproductive Hormone Findings 
According to Pubertal Status 
 
Abnormal Hormone 


















Mean Age in Years 
        (Range) 
12.6± 1.3 
           (8-18) 
9.5 ±1.3 
(8-12) 
14.3 ± 2.4 
(11-18) 
<0.0001 
     
Testosterone   



















% Free Testosterone 









FSH   

















































Note. Statistically significant values shown in boldface. *One subject was dropped from analysis 
due to missing testosterone data. †Fisher’s Exact Test. See Appendix F for normal assay ranges. 
‡Low testosterone was defined as values below the range of normal including those within the 
lowest quartile of normal range for Tanner stage. FSH-Follicle Stimulating Hormone LH-














 Data from 37 subjects were available for cardiometabolic biomarker analysis and 
are presented in Tables 4.9 and 4.10. The majority of boys were in a healthy weight 
range. Boys in the pubertal group had significantly higher BMI compared to pre-pubertal 
boys (23.7 versus 18.0; p = <0.0091).  
Mean total cholesterol concentration of the sample was 158.1 ± 35.3 mg/dL. 
While the majority of boys had total cholesterol levels within the normal range for age, 
11 (29.7%) were elevated for age. Mean HDL level of the sample was normal at 46.4 
±14.3 mg/dL. Overall, 15 boys (40.5%) had HDL lower than the recommended level for 
age. Pubertal boys demonstrated significantly lower HDL compared to pre-pubertal boys 
(40.9 mg/dL versus 55.2mg/dL; p =0.0074). Mean LDL for the total group was 87.1±34.9 
mg/dL with 11 (29.7%) demonstrating high LDL for age.  Mean triglyceride levels were 
107.6±76.5 mg/dL for the total group with 8 boys (21.6%) demonstrating elevated 
triglycerides.  
Mean glucose levels were within the normal range for the majority of subjects 
(98%). Two boys in the total sample (8.7%) had glucose levels exceeding 100 mg/dL. 
Each was referred to his pediatricians for additional monitoring and follow-up. Mean 
insulin level of the total sample was 11.8 ± 14.1 uIU/mL. Eight boys (21.6%) in the total 
sample showed abnormally high insulin levels for age.  When stratified by pubertal 
status, pre-pubertal boys showed lower insulin levels compared to the pubertal group (5.8 
uIU/mL versus 15.5 uIU/mL; p = 0.0077). The mean HOMA score of the total sample 
was 2.7 ± 4.4. Nine boys (24.3%) had HOMA values indicating insulin resistance; on 
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average, pubertal boys demonstrated higher HOMA scores compared to pre-pubertal 
boys (3.7 versus 1.2; p = 0.0059). 
 Mean HgA1c values were 5.5 ± 0.3 with 12 boys (32.4%) showing high HbA1c. 
There were no statistically significant differences between pubertal groups for mean total 
cholesterol, LDL, triglycerides, glucose or HbA1c. 
 
Table 4.9 Cardiometabolic Biomarkers by Pubertal Status  
 
Biomarker Total  
 
N= 37* 
Mean  ± SD 
 Prepubertal 
 
N = 14 
Mean± SD 
     Pubertal 
 
N = 23 
Mean ± SD 
 
 
  p-value † 
     
Age in Years 
    (Range) 
12.6 ± 3.2 
(8-18) 





     
Body Mass Index 21.5 ± 5.9 18.0 ± 3.7 23.7 ± 6.1 0.0091 
Body Mass Index Z Score 0.39 ±1.6 0.11 ± 1.6 0.57 ± 1.6 0.2940 
Total Cholesterol (mg/dL) 158.2  ± 35.3 162.93 ± 27.9 155.2 ± 39.4 0.2939 
     HDL (mg/dL)   46.4  ± 14.3 55.2 ±12.7 40.9 ± 12.5 0.0074 
     LDL (mg/dL)    87.1  ± 34.9 92.1 ± 24.4 83.9 ± 40.2 0.6860 
     Triglycerides (mg/dL) 107.6  ± 76.5 82.8 ± 44.9 122 ± 88.1 0.2019 
Glucose (mg/dL)    84 .1  ± 10.6 80.2 ± 5.0 86.5 ± 12.4 0.0747 
Insulin (uIU/mL)     11.8  ± 14.1 5.8 ± 3.6 15.5 ± 16.7 0.0077 
HOMA 2.7 ± 4.4 1.2 ± 0.79 3.7 ± 5.4 0.0059 
HbA1c  5.5  ± 0.3 5.6 ± 0.22 5.5 ± 0.29 0.4371 
*Six subjects were removed from analysis due to missing data.  † Wilcoxon Rank Sum Test.  
HDL-High density lipoproteins. LDL-Low density lipoproteins. HOMA-Homeostasis Model 



























     
Age in Years 
    (Range) 
12.6 ± 3.2 
(8-18 





     
Body Mass Index Z Score 15 (40.5) 3 (21.4) 12 (52.2) 0.0905 
Total Cholesterol (mg/dL) 
>169 
11 (29.7) 5 (35.7) 6 (26.1) 0.7130 
      HDL (mg/dL ) <45 15 (40.5) 2 (14.3) 13 (56.2) 0.0164 
      LDL (mg/dL) >99 11 (29.7) 5 (35.7) 6 (26.1) 0.7130 
Triglycerides (mg/dL) 
>110 
8 (21.6) 1 (7.1) 7 (30.4) 0.1234 
Glucose (mg/dL) >100         2 (5.4) 0 2 (8.7) 0.5165 
Insulin (mg/dL ) 
             Ages  8-13 y    <13 










HbA1c     >5.6 12 (32.4) 5 (35.7) 7 (30.3) 1.0 
HOMA    >3.16 9 (24.3) 0 9 (39.1) 0.0071 
Note. Statistically significant values shown in boldface. *All cardiometabolic biomarker normal 
standard values for pediatric ages ranges by LabCorp Inc 2009. See Appendix  G. †Six subjects 
were removed from analysis due to missing data.. ‡Fisher’s Exact test. HDL-High density 






Biomarkers for bone health are shown in Table 4.11. When stratified by pubertal group, 













Table 4.11 Bone Biomarker Characteristics by Pubertal Group (N = 32)* 
  
*Eleven subjects were removed from analysis due to missing data. † Statistical analysis by 




Mean ± SD 
Prepubertal 
 
N = 10 
Mean ± SD 
          Pubertal 
 





     
Mean Age in Years 
        (Range) 
12.7 ± 3.3 9.5 ± 1.7 14.4  <0.0001 
     
Osteocalcin in ng/mL 112.9 ± 62.1 111.7 ± 46.8 113.5 ± 69.5 0.8055 
Vitamin D, 25-
Hydroxy in ng/mL 





Psychosocial Health Characteristics 
 
 
Reliability of Psychosocial Instruments in the Sample 
 
 All psychosocial measures demonstrated good internal reliability in this sample. 
Cronbach alphas for the sample were 0.84 for the Peds QL 4.0 Quality of Life Inventory 
(Varni, et al., 1999), 0.92 for the Piers-Harris 2 Children’s Self-Concept Scale (Piers, 
1984), 0.92 for the Coopersmith Self-Esteem Inventory (Coopersmith, 2002) and 0.85 for 
the Children’s Depression Inventory (Kovacs, 1980).  Results are presented as means 
with standard deviations for total scores and all related subscales in Table 4.12   
Abnormal scores on the psychosocial health instruments are shown as frequencies and 
percentages in Table 4.13. 
 
Quality of Life 
The total sample showed average total quality of life scores of 69.9 ±16.4.  A high 
proportion of the sample (67%) showed quality of life scores below the cut-off of 80. 
Quality of life for subscales overall showed poorer scores for the physical (60.5%), 
psychosocial (79.1%), emotional (69.8%) social (58.1% and school (83.7%) domains. 
There were no differences in quality of life domains between pubertal groups with the 
exception of the school subscale that showed poorer scores in pubertal boys compared to 
pre-pubertal boys (56.5 versus 76.6; p = 0.002).  
Self-Concept 
Piers-Harris Self-Concept Scale showed that on average, the sample demonstrated 
a mean total T score of 47.4 ± 10.2 and higher than the cut-off score for the 6 domains of 
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self-concept subscales. However, 25.6 % of the sample had low total self-concept scores.   
Scores below the cut-off value were also observed for the following subscales in our 
sample: behavioral adjustment (18.6%), intellectual and school status (18.6%), physical 
attributes (11.6%), freedom from anxiety (27.9%), popularity (27.9%) and happiness 
(29.9%). There were no differences in self-concept between pubertal groups. 
 
Self Esteem 
Overall mean score for self-esteem in the total sample was 61.6 ± 21.6. Thirty-
seven percent of the boys in this sample had scores below the cutoff indicating poor self-
esteem. There were no differences in self-esteem differences between pubertal groups. 
 
Depression 
  Mean scores for depression were reported as standardized T scores. Scores 
above 54 T were considered to be clinically significant. Total mean T score for the 
sample was 48.9 ± 8.6.  Abnormally high risk for depression was seen in 16.3% of the 
boys on the total score and for subscales negative mood (16.3%), interpersonal problems 
(16.3%), ineffectiveness (18.6%), anhedonia, the inability to experience pleasure (25.6%) 
and negative self-esteem (23.3%). Two boys in the sample responded “yes” to a suicide-
screening question, “I want to kill myself” and were referred immediately for more 
comprehensive screening and consultation with a mental health professional.  There were 






Table 4.12 Psychosocial Health Scores By Pubertal Group 
 





Mean ± SD 
N = 43 
Pre-pubertal 
 
Mean ± SD 
N =16 
        Pubertal 
 
Mean ± SD 




     
Mean Age in Years 
        (Range) 







     
Quality of Life Total 69.1 ± 16.4 73.8 ± 14.4 66.4 ± 17.1 0.23 
     Physical 71.8 ± 18.5 76.4 ± 15.8 69.0 ± 19.7 0.34 
     Psychosocial 67.7  ± 16.9 72.4 ± 14.4 64.9 ± 17.9 0.23 
     Emotional 67.9 ± 20.1 65.3 ± 20.1 69.4 ± 20.3 0.64 
     Social 71.3 ± 22.4 75.3 ± 21.2 68.9 ± 23.1 0.40 
     School 63.9 ± 19.9 76.6 ± 10.9 56.5 ± 20.4 0.002 
     
Piers Harris 2 Self -Concept  
 T Scores 
 
   
      Total   47.4 ± 10.2 49.9 ± 10.4 45.9 ± 9.8  0.24 
      Behavioral Adjustment 49.4 ± 9.4 51.3 ± 9.1 48.4 ± 9.6 0.37 
      Interpersonal Problems 46.7 ± 8.8 49.9 ± 10.4 44.9 ± 7.4 0.10 
      Physical Attributes 47.1 ± 7.5 48.7 ± 6.8 46.2 ± 7.8 0.31 
      Freedom from Anxiety    47.8 ± 10.1 50.6 ± 10.9 46.0 ± 9.4 0.18 
      Popularity 45.9 ± 8.5 47.9 ± 8.3 44.7 ± 8.6 0.25 
      Happiness 44.8 ± 8.2 45.6 ± 8.8 44.4 ± 8.0 0.87 
     
Coopersmith Self Esteem     
      Total Score     61.6 ± 21.6      67.8  ± 21.7    57.9 ± 21.0  0.19 
     








       Total 48.9 ± 8.6       47.8 ± 9.6 49.5 ± 8.5 0.43 
       Negative Mood 48.6 ± 8.4 48.4 ± 9.1 48.7 ± 8.2 0.89 
       Interpersonal  
                Problems 
   50.9 ± 8.9       51.4 ± 10.8  50.5 ± 7.7       0.51 
       Ineffectiveness 49.1± 8.4      47.4 ± 8.1 50.1 ± 8.6 0.56 
       Anhedonia 48.6 ± 8.5       47.0 ± 9.3 49.6 ± 7.9 0.26 
       Negative Self Esteem    49.1 ± 11.5 48.6 ± 12.7 49.4 ± 10.8 0.88 
Note. Statistically significant values are shown in boldface. *Statistical analysis by Wilcoxon 
Rank Sum. Bonferroni criteria applied for significance. Adjusted alpha  = .008 (Quality of Life 





4.13 Frequencies of Subjects with Poor Psychosocial Health Scores by Pubertal Group  
 
Psychosocial Health  
Scores 
Total 
         N= 43 
Frequency (%) 
Pre-pubertal 
N = 16 
Frequency (%) 
Pubertal 





Mean Age in Years 
        (Range) 







     
Peds QL 4.0†     
    Total Score 29 (67.4) 9 (56.3) 20 (74.1) 0.32 
    Physical 26 (60.5) 9 (56.3) 17 (62.9) 0.75 
    Psychosocial 34 (79.1) 12 (75.0) 22 (81.5) 0.71 
    Emotional 30 (69.8) 12 (75.0) 18 (66.7) 0.73 
    Social 25 (58.1) 8 (50.0) 17 (62.9) 0.53 
    School 36 (83.7) 11 (68.8) 25 (92.6) 0.08 
     
Piers Harris 2 Self-Concept ‡    
     Total T Score 11 (25.6) 4 (25.0) 7 (25.9) 1.0 
    Behavioral    
           Adjustment 
8 (18.6) 3 (18.8) 5 (18.5) 1.0 
    Intellectual & 
School 
           Problems 
8 (18.6) 3 (18.8) 5 (18.5) 1.0 
    Physical   
           Attributes 
5 (11.6) 1 (6.3) 4 (14.8) 0.63 
    Freedom from  
           Anxiety 
12 (27.9) 3 (18.8) 9 (33.3) 0.48 
    Popularity 12 (27.9) 3 (18.8) 9 (33.3) 0.48 
    Happiness 12 (27.9) 4 (25.0) 8 (29.6) 1.0 
     
Coopersmith Self Esteem §    
     Total Score 16 (37.2) 9 (56.3) 18 (66.7) 0.53 
     
Children’s Depression Inventory (CDI) ||   
     Total T Score 7 (16.3) 3 (18.6) 4 (14.8) 1.0 
     Negative Mood 7 (16.3) 4 (25.0) 3 (11.1) 0.39 
    Interpersonal  
         Problems 
7 (16.3) 3 (18.8) 4 (14.8) 1.0 
     Ineffectiveness 8 (18.6) 2 (12.5) 6 (22.2) 0.69 
     Anhedonia 11 (25.6) 3 (18.8) 8 (29.6) 0.49 
     Negative  
           Self-Esteem 
10 (23.3) 3 (18.8) 7 (25.9) 0.72 
†Peds QL 4.0 Cut-off = <80  ‡ Piers Harris 2 Cut-off ≤ 39T  § Coopersmith Cut-off = <75  || CDI 





AIM I: To describe physical phenotype, reproductive hormones, cardiometabolic 
biomarkers and psychosocial parameters in boys with Klinefelter Syndrome (KS). 
 
Hypothesis 1.1:  KS physical phenotype as measured by the Klinefelter Syndrome 
Physical Phenotype (KSPHE) Score is inversely associated with scores for quality of 
life, self-concept, self-esteem and positively associated with depression. 
 
The associations between physical phenotype and psychosocial health measures 
were first examined using univariate linear regression. Table 4.14 presents the results of 
the univariate regression models examining the relationship between KSPHE as the 
predictor of each psychosocial dependent variable (Quality of Life, Self-Concept, Self 
Esteem and Depression).  
Quality of life total score and two of its subscales: physical and school, were 
predicted by a cumulative measure of physical traits as measured by KSPHE. The 
regression coefficients show the magnitude of decrease in total quality of life score 
(ß = -4.02; p = 0.0015), physical quality of life subscale (ß = -4.49; p = 0.0013) and 
school quality of life subscale (ß = -4.85; p = 0.0020) for each unit increase in KSPHE 
score. Each of these models were further tested using multivariate regression models.  
Testosterone, a covariate in the multivariate models, was explored both as a 
continuous (ng/dL) and as a categorical (0 = normal testosterone level for Tanner stage 
versus 1 = low testosterone for Tanner stage) variable.  
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Controlling for age and serum testosterone (ng/dL) level, the magnitude of 
decrease in Quality of Life total score remained the same (ß = -4.10; p = 0.0066) and 
22% of the variability in total quality of life score was predicted by the model (Table 
4.15).  
Physical quality of life subscale showed an additional decrease of 1 point (ß = -
5.1; p = 0.0021) compared to the univariate model when controlling for age and serum 
testosterone (ng/dL) with 24% of the variability in physical quality of life subscale score 
predicted in the multivariate model (Table 4.16).  
In a multivariate model controlling for serum testosterone (ng/dL), quality of life 
school subscale score continued to remain decreased by 4 points (ß = -4.2; p = 0.0144) 
and for age, (ß = -3.3; p = 0.0144) as predicted by KSPHE score (Table 4.17). Thirty-two 
percent of the variability in quality of life school subscale score was predicted by the 
model.   
No significant associations between KSPHE Score and self-concept, self-esteem 




Table 4.14 Univariate Linear Regression Analysis Predicting Psychosocial Health by the 
Klinefelter Syndrome Phenotype Score  (N = 43) 
 
        Klinefelter Syndrome Phenotype Index Score 
Dependent Variables Unadjusted ß SE p-value * R2 
     
Peds QL 4.0 Quality of Life     
       Total Score -4.02 1.18 0.0015 0.22 
       Physical -4.49 0.86 0.0013 0.23 
       Psychosocial -3.77 1.27 0.0050 0.18 
       Emotional -2.09 1.64 0.2106 0.04 
       Social -4.39 1.73 0.0150 0.14 
       School -4.85 1.47 0.0020 0.21 
     
Piers Harris 2 Self-Concept    
       Total T Score -1.69 0.79 0.0500 0.10 
       Behavioral Adjustment -1.25 0.76 0.1356 0.06 
       Intellectual & School -1.23 0.71 0.1096 0.07 
       Physical Attributes -0.94 0.60 0.1271 0.06 
       Freedom from Anxiety -1.54 0.81 0.0781 0.08 
       Popularity -0.89 0.69 0.2271 0.04 
       Happiness -1.15 0.66 0.1116 0.07 
     
Coopersmith Self Esteem -3.09 1.72 0.0797 0.07 
     
Children’s Depression 
Inventory 
    
       Total T Score 0.23 0.61 0.6982 0.0037 
       Negative Mood 0.24 0.58 0.6871 0.0040 
       Interpersonal     
             Problems 
0.06 0.62 0.9172 0.0003 
       Ineffectiveness -0.29 0.58 0.6187 0.0061 
       Anhedonia 0.37 0.59 0.5283 0.0098 
       Negative Self Esteem 0.29 0.79 0.7137 0.0033 
Note. Statistically significant values shown in boldface. Statistical analysis by univariate linear 
regression with independent variable: Klinefelter Syndrome Phenotype Index predicting the 
dependent variables: quality of life, self-concept, self-esteem and depression. *Bonferroni criteria 
applied for significance. Alpha = 0.008 (Quality of Life and Depression), 0.007 (Self-Concept), 
and 0.05 for Self Esteem. The regression coefficient reflects the change in psychosocial health 





Table 4.15 Multivariate Linear Regression Model Predicting Quality of Life Total Score 
by Klinefelter Syndrome Phenotype Score (KSPHE) Controlling for Age and Serum 
Testosterone Level N = (42)* 
 
 Klinefelter Syndrome Phenotype Score 
Dependent Variables Adjusted ß SE p-value  
    
Peds QL 4.0 Quality of Life Total Score   
       KSPHE Score -4.10 1.42 0.0066 
       Age   0.20 1.12 0.8581 
       Serum Testosterone Level             
                     (ng/dL) 
-0.00003 0.01 0.9817 
    
R2 0.22  
Note. Significant values shown in boldface. Statistical analysis by multivariate linear regression 
with independent variable: Klinefelter Syndrome Phenotype Index predicting the dependent 
variable: quality of life  total score controlling for age and testosterone level. The regression 
coefficient reflects the change in total quality of life score with one unit increase in KSPHE score. 
SE = standard error *One subject was removed from analysis due to missing testosterone data.  
 
Table 4.16 Multivariate Linear Regression Model Predicting Quality of Life Physical 
Score by Klinefelter Syndrome Phenotype Index (KSPHE) Controlling for Age and 
Testosterone Level N = (42)* 
 
 Klinefelter Syndrome Phenotype Score 
Dependent Variables Adjusted ß SE p-value  
    
Peds QL 4.0 Quality of Life Physical Score   
       KSPHE Score -5.1 1.6 0.0021 
       Age 0.66 1.2 0.5917 
       Serum Testosterone Level             
                     (ng/dL) 
0.002 0.01 0.8722 
    
R2 0.24  
Note. Significant values shown in boldface. Statistical analysis by multivariate linear regression 
with independent variable: Klinefelter Syndrome Phenotype Index predicting the dependent 
variable: physical quality of life and controlling for age and serum testosterone level group. The 
regression coefficient reflects the change in quality of life school score with one unit increase in 
KSPHE score. SE = standard error *One subject was removed from analysis due to missing 







Table 4.17 Multivariate Linear Regression Model Predicting Quality of Life School 
Score by Klinefelter Syndrome Phenotype Index (KSPHE) Controlling for Age and 
Testosterone Level N = (42)* 
 
 Klinefelter Syndrome Phenotype Index Score 
Dependent Variables Adjusted ß SE p-value  
    
Peds QL 4.0 Quality of Life School Score   
       KSPHE Score -4.2 1.64 0.0144 
       Age -3.3 1.28 0.0144 
       Serum Testosterone Level             
                     (ng/dL) 
0.02 0.01 0.1661 
    
R2 0.32  
Note. Significant values shown in boldface. Statistical analysis by multivariate linear regression 
with independent variable: Klinefelter Syndrome Phenotype Index predicting the dependent 
variable: quality of life for school and controlling for age and serum testosterone level group. The 
regression coefficient reflects the change in quality of life school score with one unit increase in 
KSPHE score. SE = standard error *One subject was removed from analysis due to missing 








Hypothesis 1.2: Testosterone level is positively associated with scores for quality of 
life, self-concept, self-esteem and inversely associated with depression 
 
 
Association between Psychosocial Health Measures and Testosterone Level 
 
     The associations between each psychosocial health measure and testosterone was 
examined in univariate regression models. The predictor variable, testosterone was 
explored as a continuous variable (serum testosterone in ng/dL) and as a dichotomous 
variable (low testosterone versus normal testosterone).  After applying Bonferroni criteria 
to adjust alpha, there was no association between KSPHE score and Psychosocial Health 
scores (Table 4.18).  
Using testosterone as a dichotomous variable, there was a positive association 
between the Interpersonal Problems subscale of the CDI and low testosterone (ß = 10.6; p 
= 0.003) as shown in Table 4.19. Adjusting for age, the multivariate linear model 
predicting interpersonal problem score on the CDI remained significant (ß = 10.56; p = 
0.0046) as shown in Table 4.20. The regression coefficient shows an increase in CDI 
Interpersonal Problem score of over 10 points predicted by low testosterone. This model 







Table 4.18  Univariate Linear Regression Model Predicting Psychosocial Health 
measures by Serum Testosterone (N = 42)* 
 
 Serum Testosterone 
Dependent Variables Unadjusted ß SE p-value † R2 
     
Peds QL 4.0 Quality of Life     
       Total -0.01185 0.00534 0.0323 0.1096 
       Physical -0.00874 0.00646 0.1833 0.0438 
       Psychosocial -0.01350 0.00580 0.0251 0.1192 
       Emotional -0.01267 0.00923 0.1776 0.0450 
       Social -0.01277 0.00863 0.1467 0.0519 
       School -0.01505 0.00760 0.0545 0.0893 
      
Piers Harris 2 Self-concept     
       Total -0.00657 0.00538 0.2292 0.0359 
       Behavioral Adjustment -0.00458 0.00505 0.3705 0.0201 
       Intellectual & School -0.00748 0.00467 0.1173 0.0602 
       Physical Attributes -0.00328 0.00407 0.452 0.0160 
       Freedom from Anxiety -0.00724 0.00537 0.1854 0.0434 
       Popularity -0.00441 0.00461 0.3444 0.0224 
       Happiness -00218 0.00446 0.6277 0.0059 
     
Coopersmith Self Esteem -0.01468 0.01157 0.2119 0.0387 
     
Children’s Depression 
Inventory 
    
       Total 0.00321 0.00483 0.5096 0.0109 
       Negative Mood 0.00560 0.00454 0.2242 0.0367 
       Interpersonal Problems -0.00361 0.00485 0.4610 0.0137 
       Ineffectiveness 0.00469 0.00436 0.288 0.0281 
       Anhedonia 0.00185 0.00465 0.6937 0.0039 
       Negative Self Esteem 0.00314 0.00622 0.6165 0.0063 
 *One subject was removed from analysis due to missing testosterone value. Statistical 
analysis by simple linear regression with independent variable: serum testosterone 
predicting the dependent variables: quality of life scores.  †Bonferroni criteria applied for 
significance. Alpha  = .008 (Quality of Life and Depression), .007 (Self-Concept), and 






Table 4.19  Univariate Linear Regression Model Predicting Psychosocial Health 
measures by Low Testosterone (N = 42)* 
 
 Low Testosterone* 
Dependent Variables Unadjusted ß SE p-value † R2 
     
Peds QL 4.0 Quality of Life     
       Total  2.08 6.80 0.76 0.0023 
       Physical -0.36 7.54 0.96 0.0001 
       Psychosocial  3.38 7.09 0.64 0.0056 
       Emotional -1.86 8.53 0.83 0.0012 
       Social  8.71 9.20 0.35 0.0219 
       School  3.28 8.39 0.69 0.0038 
      
Piers Harris 2 Self-concept     
       Total -3.00 4.21 0.48 0.01 
       Behavioral Adjustment  0.49 3.94 0.90 0.004 
       Intellectual & School -1.45 3.72 0.69 0.004 
       Physical Attributes -1.31 3.17 0.68 0.004 
       Freedom from Anxiety -3.69 4.21 0.39 0.02 
       Popularity -5.0 3.51 0.16 0.05 
       Happiness -3.6 3.41 0.29 0.03 
     
Coopersmith Self Esteem -11.2 8.95 0.22 0.04 
     
Children’s Depression 
Inventory 
    
       Total 2.2 3.74 0.56 0.0086 
       Negative Mood -5.0 3.49 0.15 0.05 
       Interpersonal Problems 10.6 3.38 0.003 0.20 
       Ineffectiveness 2.5 3.39 0.46 0.01 
       Anhedonia 3.37 3.56 0.35 0.02 
       Negative Self Esteem -0.74 4.82 0.88 0.0006 
Note. Statistically significant values shown in boldface *One subject was removed from analysis 
due to missing testosterone value. Statistical analysis by simple linear regression with 
independent variable: testosterone predicting the dependent variables: quality of life scores 
Statistical significance of simple models at p = 0.05   Low normal testosterone as a dichotomous 
variable defined as serum testosterone ≤ midway between the bottom of the normative range and 
mean for Tanner stage of sexual development. † Bonferroni criteria applied for significance. 
Alpha  = .008 (Quality of Life and Depression), .007 (Self-Concept), and .05 for Self Esteem. SE 




Table 4.20 Multivariate Linear Regression Model Predicting Interpersonal Problems by 
Low Testosterone Controlling for Age (N= 42)* 
 
 CDI Interpersonal Problems 
Independent Variables Adjusted  ß SE p-value 
    
Low Testosterone † 10.56 3.50 0.0046 
Age     0.05 0.63 0.9303 
    
R2   0.20   
Note. Statistically significant values show in boldface. *One subject was removed from analysis 
due to missing testosterone value. Statistical analysis by multivariate linear regression with 
independent variable: low testosterone predicting the dependent variable: CDI Interpersonal 
Problems.   † Low normal testosterone as a dichotomous variable defined as serum testosterone at 









Hypothesis 1.3 Physical phenotype as measured by the Klinefelter Syndrome 
Phenotype (KSPHE) Score is inversely related to testosterone. 
 
 The association between physical phenotype and testosterone was examined in a 
univariate regression model using the predictor variable testosterone as a continuous 
variable (serum testosterone in ng/dL) and as a dichotomous variable (low testosterone 
versus normal testosterone). Table 4.21 provides details regarding the results of the 
univariate analysis with testosterone as a continuous variable. For each unit increase in 
testosterone, KSPHE score increases by 0.003 units (ß = 0.00329; p = 0.0006) After 
controlling for age, the multivariate linear model shown in table 4.22 remains significant 
(ß = 0.00293; p = 0.0332). This model demonstrates that for each unit increase in 
testosterone (ng/dL), KSPHE score increases by 0.00293 while controlling for age. 
Twenty-seven percent of the variance in KSPHE can be explained by this model. 
 
Table 4.21 Univariate Linear Regression Model Predicting Klinefelter Syndrome  






Independent Variable Adjusted ß SE p-value  
     
Serum Testosterone  0.00329 0.0008 0.0006 0.02559 
     
Note statistical significance shown in boldface.* One subject was removed from analysis due to 
missing testosterone value. The regression coefficient reflects the change in KSPHE with 1 unit 






Table 4.22 Multivariate Linear Regression Model Predicting Klinefelter Syndrome 
Phenotype (KSPHE) Score by Serum Testosterone Controlling for Age (N= 42)* 
 
 KSPHE Score 
Independent Variables Adjusted  ß SE p-value 
    
Serum Testosterone † 0.00293 0.001 0.0332 
Age 0.04578 0.125 0.7170 
    
R2 0.27   
Note. Statistically significant values show in boldface. *Six subjects were removed from analysis 
due to missing values. Statistical analysis by multivariate linear regression with independent 
variable: serum testosterone predicting the dependent variable: KSPHE score.  † Serum 
testosterone used as a continuous variable. The regression coefficient reflects the change in 
KSPHE Score with one unit increase in serum testosterone while controlling for age and 
pubertal group. 
 
A univariate model presented in Table 4.23 using testosterone as a dichotomous variable 
did not show a relationship between KSPHE and low testosterone. 
 
Table 4.23 Univariate Linear Model Predicting Klinefelter Syndrome (KSPHE) Score by 
Low Testosterone (N = 42)* 
 
 Klinefelter Syndrome Phenotype Score  
R2 
Independent Variable Adjusted ß SE p-value  
     
Low Testosterone † -0.51 0.79 0.5187 0.0105 
     
One subject was removed from analysis due to missing testosterone value. Statistical analysis 
conducted by univariate linear regression with independent variables low testosterone predicting 
phenotype by the Klinefelter Syndrome Phenotype Index. † Low testosterone used as a 
dichotomous variable with defined as at or below the lowest quartile of the normative range for 











Hypothesis 1.4 Testosterone levels are negatively associated with total cholesterol 
and insulin resistance as measured by the Homeostasis Model Assessment. 
  
 Table 4.24 provides results of the univariate linear regression model examining 
the association the association between serum testosterone as a continuous variable and 
each cardiometabolic biomarker. Results of univariate linear models shown in Table 4.24 
demonstrate that serum testosterone is a significant predictor of BMI  (ß = 0.012; p = 
0.0005) and HDL (ß = -0.024; p = 0.0012). When controlling for age in multivariate 
analyses, however, there is no relationship between testosterone and BMI (Table 4.25). 
 
Table 4.24 Univariate Linear Regression Model Predicting Cardiometabolic 
Measurements by Serum Testosterone  (N = 37)* 
 
 Serum Testosterone † 
Dependent Variables Unadjusted ß SE p-value R2 
     
BMI 0.012 0.00 0.0005 0.2965 
BMI Z 0.000 0.00 0.1294 0.0645 
Total Cholesterol -0.013 0.02 0.4901 0.0137 
High Density Lipoproteins -0.024 0.01 0.0012 0.2619 
Low Density Lipoproteins -0.024 0.02 0.2231 0.0421 
Triglycerides 0.070 0.04 0.1011 0.0749 
Homeostasis Model 
Assessment 
0.000 0.00 0.9840 0.0000 
Hemoglobin A1c 0.000 0.00 0.6476 0.0062 
*Six subjects were removed from analysis for missing data  (6 for missing glucose and 1 outlier 
due to hyperglycemic value). Statistical analysis conducted by univariate linear regression. SE = 




Table 4.25 Multivariate Linear Regression Model Predicting Body Mass Index by Serum 
Testosterone Controlling for Age (N= 37)* 
 
 Body Mass Index (BMI) 
Independent Variables Adjusted  ß SE p-value 
    
Serum Testosterone † 0.00699 0.00413 0.0999 
Age 0.48821 0.38224 0.2102 
    
R2 0.33   
 *Six subjects were removed from analysis due to missing values. Statistical analysis by 
multivariate linear regression with independent variable: serum testosterone predicting the 
dependent variable: body mass index.   † Serum testosterone used as a continuous variable. 
 
 
Controlling for serum testosterone (ng/dL) and age (Table 4.26), the multivariate model 
demonstrates that HDL decreases by 8.35 mg/dL with each unit increase in age (ß = -
8.35; p = 0.0248). This model explains 36% of the variability in HDL. 
 
Table 4.26 Multivariate Linear Regression Model Predicting High Density Lipoproteins 
by Serum Testosterone Controlling for Age (N= 37)* 
 
 High Density Lipoproteins (HDL) 
Independent Variables Adjusted  ß SE p-value 
    
Serum Testosterone † -0.00784 0.00965 0.4225 
Age -8.35093 5.148 0.0248 
    
R2 0.36   
 *Six subjects were removed from analysis due to missing values. Statistical analysis by 
multivariate linear regression with independent variable: serum testosterone predicting the 
dependent variable: high density lipoproteins.   † Serum testosterone used as a continuous 
variable. The regression coefficient reflects the change in HDL with one unit increase in serum 
testosterone controlling for age. 
 
 
Using testosterone as a dichotomous variable in a univariate analysis, there were no 
positive associations between low testosterone and cardiometabolic biomarkers. 
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Table 4.27 Univariate Linear Regression Model Predicting Cardiometabolic 
Measurement by Low Testosterone (N = 37)* 
 
 Low Testosterone † 
Dependent Variables Unadjusted ß SE p-value ‡ R2 
     
BMI -1.27   2.52 0.6165 0.0072 
BMI Z -0.09   0.69 0.8885 0.0006 
Total Cholesterol -6.68 14.98 0.6582 0.0057 
High Density Lipoproteins -1.14   6.10 0.8525 0.0010 
Low Density Lipoproteins -2.17 14.84 0.8842 0.0006 
Triglycerides 3.17 32.57 0.9229 0.0003 
Homeostasis Model 
Assessment 
 4.01   1.74 0.0269 0.1322 
Hemoglobin A1c -0.09   0.11 0.4583 0.0163 
Note. Statistically significant values shown in boldface.*Six subjects were removed from analysis 
for missing data  (5 for missing glucose and 1 outlier due to hyperglycemic value). Statistical 
analysis conducted by univariate linear regression. SE = standard error. † Low testosterone used 
as a dichotomous variable defined as values below the range of normal including those within the 









Body Composition and Bone Mineral Density Retrospective Review Study 
 
 
Aim II. To describe body composition and bone mineral density in a sample of 
Klinefelter Syndrome Boys 
 
Hypothesis 2.1 Boys with Klinefelter Syndrome have higher percent body fat as 
measured by DEXA compared to boys from a normative reference standard. 
 
Hypothesis 2.2 Boys with Klinefelter Syndrome have lower bone mineral density as 
measured by DEXA compared to boys from a normative reference standard. 
Results 
Demographic characteristics of the sample are shown in Table 4.28. 
Mean age of the boys was 13.5 ± 3.2 years. The majority of the sample was Caucasian 
(80%).   
Bone mineral density in gm/cm2 is reported as Z scores. Table 4.29 presents the 
mean bone mineral and body composition measurements of the sample. On average, 
TBBMD Z scores were within the normal range (Z = 0.045) while mean AP Spine Z 
scores fell between 0 and 2 standard deviations below the mean (Z = -0.61).  BMI, a 
proxy measure of body fat according to height, weight and age showed a mean Z score of 
-0.23.  Percent body fat by DEXA showed an overall mean fat percent of 29.35 ± 
12.55%. Mean total testosterone level for this group was 168.1 ng/dL ± 187.9 ng/dL.   
Figure 4.1 illustrates AP Spine Z scores for the sample compared to normal AP 
Spine Z ranges for age and ethnicity.  Four boys (20%) had AP spine Z scores falling at 
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or below 2 standard deviations, while an additional 5 boys fell between 1 and 2  standard 
deviations below the mean.   
 
Table 4.28 Demographic Characteristics for the Bone Mineral and Body Composition 
Sample  (N = 20) 
 
Characteristic Mean ± SD 
Age 13.5 ± 3.2 
  
 Frequency (%) 
Race  
     Caucasian 16 (80) 
     African American 1 (5) 
     Hispanic   2 (10) 
     Asian 1 (5) 
 
 
Table 4.29 Mean Bone Mineral Density Z Scores and Body Composition (N = 20) 
Variable Mean ± SD Range 
Total Body Bone Mineral Density Z 0.045 ± 1.1 -2.4, 1.6 
Anterior-Posterior Lumbar Spine Z -0.61 ± 0.94 -2.5, 0.8 
BMI Z Score -0.11 ± 2.0 -4.93, 2.89 
 % Body Fat by DEXA 29.35 ± 12.5 5.8, 54.6 
Serum testosterone (ng/dL) 168.12 ±187.96 0.4-586 
Results reported as Means ± standard deviation (SD) and frequencies with percentages. 








Figure 4.1 Lumbar Bone Mineral Density (AP Spine BMD Z) by Age  
  Filled circle represents one subject. Z Scores -1 = one SD below the mean, 0 = Mean, 
+1 = one SD above the mean. 
 
 
 The relationship between bone mineral density and age was examined using 
univariate linear regression. Results are presented in Table 4.30.  An inverse association 
exists between bone mineral density and age.  AP Spine Z score decreases by 0.13 with 
each unit increase in age (ß = -0.13; p =0.047), and TBBMD Z decreases by 0.17 with 
each unit increase in age (ß = -0.17; p =0.012). There were no associations between age 























Age in Years 





Table 4.30 Univariate Linear Regression Model Predicting Bone Mineral Density and 
Body Fat by Age (N= 20) 
 
 Age in Years 
 Unadjusted ß      SE p-value R2 
Dependent Variable     
     
 Anterior-Posterior Lumbar 
Spine Z 
-0.13 0.0605 0.047 .20 
 Total Body Bone Mineral 
Density Z 
-0.17 0.0639 0.012 .30 
   %  Body Fat by DEXA  -0.41 0.9012 0.6565 0.01 
     
Note. Statistically significant values shown in boldface. Analysis by univariate linear 
regression. DEXA = Dual Energy X-Ray Absorptiometry. SE = standard error 
 
 
A relationship was seen between percent body fat and bone mineral density. Table 
4.31 presents results of univariate regression models with percent body fat as a predictor 
of bone mineral density. Results demonstrate that AP Spine Z score increases by 0.05 
with every percent increase in body fat (ß = 0.05; p = 0.0022) and TBBMD Z score 
increases 0.06 with every percent increase in body fat (ß = 0.06; p = 0.0016). 
 
Table 4.31 Univariate Linear Regression Model Predicting Bone Mineral Density Z 
Scores by % Body Fat (N=20) 
 
 % Body Fat by DEXA 
 Unadjusted ß SE p-value R2 
Dependent Variable     
     
 Anterior-Posterior Lumbar 
Spine Z 
0.05 0.0134 0.0022 0.4153 
 Total Body Bone Mineral 
Density Z 
0.06 0.0149 0.0016 0.4351 
     
Note. Statistically significant value shown in boldface.  Analysis by univariate linear 





Relationships were further examined by univariate regression with independent variables: 
Weight in kg and Body Fat in kg predicting bone mineral density Z scores, respectively 
shown in tables 4.32 an 4.33. Neither weight (kg) nor body fat (kg) were significant 
predictors of bone mineral density. Body fat (kg), however, appeared to approach 
significance as shown in Table 4.33. A larger sample size may have shown significance. 
 
 
Table 4.32 Univariate Linear Regression Model Predicting Bone Mineral Density Z 
Scores by Weight (kg). (N = 20) 
 
 Weight in kg 
 Unadjusted ß SE p-value R2 
Dependent Variable     
     
 Anterior-Posterior Lumbar 
Spine Z 
0.00936 0.00794 0.2539 0.0716 
 Total Body Bone Mineral 
Density Z 
0.00730 0.00916 0.4361 0.0340 
     
SE = standard error 
 
Table 4.33 Univariate Linear Regression Model Predicting Bone Mineral Density Z 
Scores by Body Fat (kg) (N = 18*) 
 
 Body Fat in kg 
 Unadjusted ß SE p-value R2 
Dependent Variable     
     
 Anterior-Posterior Lumbar 
Spine Z 
-0.00002293 0.00000 0.0569 0.2083 
 Total Body Bone Mineral 
Density Z 
-0.00002311 0.00000 0.0607 0.2028 
     
* Two subjects were removed from analysis for missing data. SE = standard error 
 
 
Table 4.34 displays the results of univariate regression analysis of serum testosterone as a 
predictor of bone mineral density. For every unit increase in testosterone, TBBMD Z 
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decreases by 0.004 (ß = -0.004; p = 0.0028). There were no relationships between serum 
testosterone and AP Spine Z score. 
 
Table 4.34 Univariate Linear Regression Model Predicting Bone Mineral Density Z 
Scores by Serum Testosterone  (N = 19*) 
 
 Serum Testosterone (ng/dL) 
Variable Unadjusted ß     SE p-value R2 
     
Dependent Variable     
 Anterior-Posterior Lumbar 
Spine Z 
-0.002 0.0011 0.0846 0.16 
 Total Body Bone Mineral 
Density Z 
-0.004 0.0011 0.0028 0.42 
     
     
Note. Statistically significant values shown in boldface. *One subject was removed from 








Summary of Study Findings 
 Guided by an adaptation of Engel’s Biopsychosoocial Model of Health, this 
exploratory study examined for the first time, relationships among physical phenotype, 
reproductive hormones, cardiometabolic, bone and body composition biomarkers and 
psychosocial health parameters in a convenient cross-sectional sample of boys with 
Klinefelter Syndrome (Aim 1).  The KS phenotype was characterized using an 
investigator-developed scale to quantify the 13 most commonly reported features 
identified from the literature and verified by experts in pediatric medicine. As a 
secondary aim, bone mineral density and body composition were examined by 
retrospective chart review 
 Of the 43 KS boys who participated in Aim 1, the majority were Caucasian, had 
reached at least Tanner stage 2 of pubertal development with an overall mean age of 12.5 
years, BMI of 21.6 and a cumulative KSPHE score of 5.1 (maximum score of 13). 
Eighty-five percent of the sample exhibited testosterone concentrations in the normal 
range with 50% showing elevated gonadotropins indicative of early gonadal failure. 
Serum testosterone was shown to be positively related to the KSPHE score.  
Approximately a third of the sample showed elevated cholesterol with higher proportion 
demonstrating reduced HDL (40.5%). Almost 25% showed insulin resistance as 
measured by HOMA. Cardiometabolic risk was not restricted to overweight boys. A 
significant minority of boys with normal weight showed waist circumference greater than 
the 90th percentile (n = 5; 21.7%), elevated total cholesterol (n= 5 21.7%); reduced HDL  
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(n = 3, 13.0%), elevated triglycerides (n= 2; 8.7%%), elevated insulin (n= 2, 8.7%) and 
elevated HOMA (n= 6; 26.1%). Serum testosterone was not associated with 
cardiometabolic measures. 
Psychosocial health measures showed a high percentage of boys with poor quality 
of life (n = 29; 67.9%) with a quarter showing reduced self-concept (n = 11; 25.6%), over 
a third with reduced self-esteem (n= 16; 37.2%) and less than a fifth with depression (n= 
7; 16.3%). No differences in psychosocial health scores were observed between pubertal 
groups. KSPHE score was inversely associated with quality of life scores, but not for 
self-concept, self-esteem or depression. 
 
Aim I  Demographic and Clinical Characteristics 
Compared to other studies of boys with KS ((Ross, et al., 2008; Wikstrom, 
Painter, et al., 2006; Zeger, et al., 2008), the mean age of boys in the current study was 
older (12.5 years) and represented boys across all stages of pre, early and pubertal sexual 
maturation (Tanner stages 1-5). The majority of boys in our sample had non-mosaic KS 
(90.6%). The group was primarily Caucasian (86.0%) with parents educated beyond a 
high school education (95.3%). Over half of the boys had received testosterone therapy at 
some time in their lives (51.1%). Almost 63% of the children were aware of their 
diagnosis with KS. A high proportion of participants were in school grades appropriate 
for age (90.7%) with more than half having their education directed by Individualized 
Education Plans (55.8%). A majority of the sample had received speech and language 
therapy (76.7%) followed by occupational therapy (58.1%), physical therapy (41.9%) and 
psychiatric therapy (37.1%). According to parent report, the current sample demonstrated 
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histories of speech and language problems (67.4%), learning difficulties (69.8%), ADHD 
(37.2%), autism spectrum disorder (14.6%), behavior issues (53.5%) and psychiatric 
problems (20.9%).  Two recent studies of comparable populations found similar 
demographic characteristics. 
Bruining et al. (2009), in a sample of Dutch boys with KS found similar 
prevalence of speech and language problems in 65% and learning disorder in 63%, with 
higher rates of ADHD (63%) and autism spectrum disorder (27%) and a lower rate of 
behavioral/psychiatric disorders (12%) compared to the current study. The sample 
included a wider range of ages (6-19 years) with the largest group being under 12 years 
of age and also primarily Caucasian. Standardized instruments were used to measure 
learning problems, psychiatric disorders and autism spectrum disorder in contrast to the 
parent-report of problems in the current study.  
In a 2009 study comparing 93 KS boys (47, XXY) with 21 (47 XYY) boys with 
36 unaffected age-matched controls, Ross et al. (Ross, et al., 2009) reported that 81% of 
the KS boys had received speech and language therapy, 89% received special educational 
therapies and that 66% had received occupational or physical therapy in the past. The 
sample ranged in age from 4.1 years to 17.8 years (mean age 9.4) and was also primarily 
Caucasian. KS boys of non-Caucasian race are poorly represented in current studies on 
KS in children. This observation may reflect barriers to diagnosis or limitations to health 









Physical Phenotype Characteristics 
 
 
 The phenotype of boys in this study was highly variable with some individuals 
showing very few physical characteristics while others demonstrated multiple 
reproductive somatic traits. The KSPHE score, as a measure of somatic involvement, 
revealed that on average, our sample number had 5 KS-related characteristics with a 
range of 1-12. As expected, boys in the current study who had entered puberty were taller 
and heavier, with higher BMI, larger testicular volume and longer phallic length 
compared to the pre-pubertal group. There were no differences between pubertal groups 
with regard to other KS-related physical characteristics such as gynecomastia, 
clinodactyly, skeletal abnormalities or hand tremor. Skeletal abnormalities such as 
scoliosis, pectus excavatum and pectus carinatum have been reportedly sporadically in 
the KS literature primarily in case reports on older adolescents or adults (Bojesen & 
Gravholt, 2007). In this small sample, there were 4 affected boys (9.3%) 2 with scoliosis 
and 2 with pectus abnormalities. Clinodactyly is a frequent finding in KS (Zeger, et al., 
2008). Fifteen of the boys (53.5%) showed this skeletal trait.  High-arched palate was 
more frequently present in the pubertal group (55.6%) compared to the pre-pubertal 
group (18.8%). There is no evidence in the literature that explains why high-arched palate 
would be more frequent in pubertal children versus pre-pubertal children.  
Height greater than the 90th percentile was observed in 37.2% of the sample with 
more than half of the boy demonstrating longer lower segment height compared to upper 
segment height. A BMI at or above the 85th percentile was seen in 44.2% of the sample 
with waist circumference greater than the 90th percentile observed in 25.8%. As a 
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surrogate measure of body fat distribution, the increased waist circumference suggests 
that an unhealthy distribution of body fat may be seen during childhood in KS boys.  The 
general prevalence of overweight in adolescents in the US is reported to be 
approximately 17% (CDC, 2011). The proportion of overweight in our sample is much 
higher than that of healthy adolescents. 
There are only 2 studies on physical characteristics of children with KS. Many of 
the physical trait findings seen in the current study: small testicular volume (69.8%), 
short phallus (37%) and clinodactyly (53.5%) are similar to the observations of Giardin et 
al. (2009) who conducted a retrospective review of medical records between 1989 and 
2006 of 28 Canadian boys between the ages of 12 and 18 years. These investigators 
compared the phenotypes of adolescents diagnosed by amniocentesis or postnatally 
postulating that boys diagnosed prenatally would have a more heterogeneous and less 
severe phenotype than boys diagnosed postnatally (Girardin, et al., 2009). They reported 
an expected high proportion of boys demonstrating tall stature, long legs and reduced 
testicular volume; however, fewer boys were overweight despite a higher percentage 
demonstrating gynecomastia (59.1%) compared to our study. The Giardin et al. study 
retrospectively collected data from a 17-year period. Differences in overweight between 
this study and ours may be due to differences in obesity rates with a Canadian population 
compared to the US, or lower prevalence of overweight in the past compared to the 
present. A higher rate of gynecomastia may be due to measurement technique differences 
among different observers. 
In a 2008 cross-sectional study with 55 KS children between the ages of 2-14 
years, Zeger et al. (2008) reported higher rates of most features including clinodactyly 
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(74%), small testicular volume (69%), hypertelorism (69%) gynecomastia (44%) and 
short phallus for age than those observed here; rates for skeletal abnormalities (8% with 
scoliosis were similar.  To what extent these differences may be due to measurement 
technique or the variability of phenotypic features across cohorts is not clear. 
 
Klinefelter Syndrome Phenotype (KSPHE) Score 
 The KSPHE scoring system was created to quantify the extent of KS-related 
physical trait abnormalities using an investigator-developed tool. Its development was 
modified from an existing scale for the description of phenotype in Anderson-Fabry 
syndrome and was guided by the literature in consultation with advice from pediatric 
endocrinologists at the tertiary care center for KS patients at CUMC. The Mainz Severity 
Score Index (MSSI) is a scoring mechanism for quantifying the Anderson-Fabry 
phenotype (Whybra, et al., 2004). Anderson Fabry disease (AFD) is an X-linked multi-
systematic liposomal storage disorder that first appears in childhood. The scoring system 
is composed of 4 sections that cover symptoms including general, neurological, 
cardiovascular and renal systems. The symptoms were weighted according to their 
contribution to the morbidity of disease. Some symptoms were rated 0 or 1 for the 
presence or absence of a characteristic or symptom (such as characteristic facies, 
presence of edema, musculoskeletal symptoms, corneal verticillata, diarrhea or 
hemorrhoids). Other symptoms (presence of angiokeratoma, diaphoresis, abdominal pain, 
pulmonary symptoms) had a more extended scale from 0, 1, or 2 with 2 representing 
higher morbidity to the patient. The score for cardiovascular symptoms was based on the 
New York Heart Association for classes of heart disease rated I-IV, with corresponding 
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MSSI scores ranging from 1 to 4 with 4 indicating worse cardiac morbidity. The 
cumulative score for the MSSI ranges from 0 –20 with 20 representing the highest 
morbidity or severity.  The MSSI has been used for the purpose of objectively rating 
severity of AFD and for monitoring enzyme replacement therapy treatment effects 
(Parini, et al., 2008b; Whybra, et al., 2004).  
The KSPHE score uses a cumulative index indicating the presence or absence of 
the most common characteristics observed in KS.  It does not measure severity or 
morbidity per se. A higher score on the KSPHE indicates a greater overall number of 
characteristics; i.e. a physical phenotype that is more clinically recognizable by 
observation than a KS individual with a lower score. The KSPHE phenotype score, 
however, requires further testing for reliability and validity in other settings with multiple 
observers. Its utility as a clinical or research measure must be regarded with caution until 
further development and testing can be accomplished. Further development of the 
KSPHE is also recommended to include weights applied to those features that may 
contribute more heavily toward morbidity for the patient, thus becoming a future measure 
of severity. 
 
Reproductive Hormone Characteristics 
 
Reproductive hormone levels in our sample showed expected differences in 
hormone concentrations between pre-pubertal versus pubertal boys. Elevated LH, FSH 
and estradiol were seen in the pubertal group compared to the pre-pubertal group and is 




Although this sample of 43 peri-pubertal KS boys, showed wide variability in 
serum testosterone concentrations, the majority of boys (83.3%) exhibited testosterone 
values within the normal range for Tanner stage. Boys with low testosterone levels 
(16.7%) were equally distributed between the pre-pubertal and pubertal group.  The 
estrogen/testosterone ratio was higher in prepubertal boys compared to pubertal boys. For 
the pubertal group, estrogen/testosterone ratios were within the normal range (LaFranchi, 
Parlow, Lippe, Coyotupa, & Kaplan, 1975). While approximately half of the boys 
showed evidence of testicular failure due to elevated gonadotropins, the majority of boys 
did not show evidence of androgen deficiency. Sex hormone binding globulin was within 
the normal range for 88% of the boys and DHEAS was within the reference range for 
normal in 61%. 
Two other investigators have recently studied testosterone production in KS boys 
and reached conflicting conclusions about the presence of androgen deficiency during 
peri-pubertal development. In support of the current findings, Wikstrom and colleagues 
(Wikstrom, Dunkel, et al., 2006), examined 14 Finnish boys between the ages of 10 and 
14 years for signs of androgen deficiency and then prospectively followed the sample for 
a period of 3 years to observe their hormonal status.  All 14 boys had a normal onset and 
progression of puberty and serum testosterone was within the normal range for Tanner 
stage of development throughout the follow-up period. However, despite normal serum 
testosterone concentrations, LH and FSH showed an exaggerated response to 
gonadotropin-releasing hormone. The researchers concluded that androgen deficiency 
was not yet present in these boys and androgen supplementation therapy was not required 
during early puberty.   
  120 
 
In contrast, Zeger et al. (2008), with a US sample of 55 boys between the ages of 
2 and 14 years found that 75% had testosterone levels below the 25th percentile for 
Tanner stage; a much higher frequency than observed here or reported by Wikstrom et al. 
In the current study, there were high proportions of boys with elevated LH (n= 21; 50%) 
and FSH (n = 18; 42.9%) in keeping with a gonadotropin profile associated with onset of 
testicular failure (Aksglaede, et al., 2006; Wikstrom & Dunkel, 2008; Wikstrom, et al., 
2004). Taken together, the evidence to date suggests that early gonadal failure is a 
common finding in KS boys, but conflicting evidence remains concerning whether peri-
pubertal boys are androgen deficient.  
 Estradiol concentrations were within the range of normal (n=  39; 92.9%) in our 
study. Zeger et al. reported undetectable estradiol in their sample that may be due to the 
younger ages  (2-14 years) of participants overall or to differences in assay sensitivity. 
Wikstrom et al. observed that 10-12 year old KS boys had higher estradiol compared to 
older KS boys, a finding that was not observed in our study. The estrogen/testosterone 
ratio, however, was within the normal range for participants in our study confirming the 
similar finding in the Wikstrom et al.  
Wikstrom et al. reported sex hormone binding globulin to be within the normal 
range in their sample. This finding was also similar to the findings of the current study 
where 88.1% of the sample had sex hormone binding globulin within the normal range. 
Taken together, just 112 affected boys from these 3 studies have been collectively 
assessed for abnormalities in the KS reproductive axis. In order to reconcile some of the 
discrepant findings, larger cohorts will need to be assessed using similar assay methods 




Cardiometabolic Health Characteristics 
Results from our study suggest that peri-pubertal KS boys exhibit increased 
cardiometabolic risk well before adulthood. Overall, the BMI Z score above the first 
standard deviation ( ≥ 85th percentile) was present in over 40% of the sample and waist 
circumference above the 90th percentile was observed in approximately 26%. Blood lipid 
measurements demonstrated that nearly 30% of the sample had elevated total cholesterol 
and LDL with over 40% showing HDL levels below the desired range. Elevated serum 
triglycerides were observed in almost 22% of the sample. Although glucose values were 
normal in all but 2 of the boys in this sample, insulin was elevated in approximately 21% 
with nearly a quarter of the sample (24%) demonstrating insulin resistance as measured 
by HOMA. HbA1c, a measure of long term average plasma glucose concentration showed 
values above normal pediatric reference range for healthy children (Esoterix & LabCorp, 
2010). As this is one of two studies to examine glucose regulation in KS boys, more 
studies will be needed to clarify the frequency of this adverse health indicator as a 
common problem in KS. 
The adverse cardiometabolic profiles reported here are consistent with those of 
Bardsley et al. (2011) who studied cardiometabolic health parameters in a sample of 89 
young KS boys who were primarily pre-pubertal (ages 4-12 years). In that study, the 
authors observed the following rates of abnormal findings: elevated total cholesterol in 
40%, elevated triglycerides in 15%, elevated LDL in 37%, reduced HDL in 65%, and 
insulin resistance in 24%.   
  122 
 
Although these data are worrisome, the interpretation of an enhanced 
cardiometabolic risk in KS children must be made cautiously. Normal developmental 
changes that are mediated by growth and puberty in healthy boys may explain at least 
part of the cardiometabolic risk findings (Moran, et al., 2007). In a study of over 500 
healthy school children, Moran et al. found that insulin resistance was lower in males at 
11 years of age, but climbed steadily to 19 years of age. This was not observed in female 
children. The investigators concluded that during adolescence, insulin resistance 
increased in males, as did triglycerides with a concomitant decrease in HDL suggesting 
that this may represent increased cardiovascular risk overall in healthy males. 
In addition to conventional cardiometabolic biomarkers, osteocalcin and vitamin 
D levels from the cross-sectional study were evaluated for the first time in KS boys and 
found to be in the normal reference range for age. Recently, osteocalcin, a presumed 
biomarker of bone health, has been implicated as an important regulator for insulin 
resistance. Animal models using mice have shown that osteocalcin, which is a bone-
derived hormone, is associated with insulin secretion (Lee, et al., 2007). Mice lacking 
osteocalcin display glucose intolerance and a decreased ß cell proliferation in the 
pancreas (Lee & Karsenty, 2008a). Lee et al. suggest that the skeleton exerts an 
endocrine regulation of glucose homeostasis and that the skeleton itself may be an 
endocrine organ. In this cohort of KS boys where insulin resistance was present in a 
quarter of the sample, a role for disordered osteocalcin secretion does not appear to be 
evident. 
 




 There is a paucity of research examining psychosocial health in adults and 
children with KS. Poor psychosocial health has been shown to be associated with other 
endocrine abnormalities such as polycystic ovary syndrome (Hahn, Tan, et al., 2005; 
McCook, et al., 2005) and Turner Syndrome (McCauley, Ito, & Ray, 1986).  
In the current study, KS boys demonstrated reduced quality of life (n= 29; 67.4%), low 
self-concept (n = 11; 25.6%), low self-esteem (n = 16; 37.2%) and depression (n =7; 
16.3%). The current study tested associations between the KS physical phenotype, serum 
testosterone and psychosocial health measures. 
 
Quality of Life 
Findings of the current study suggest that a high proportion of boys with KS 
(67.4%) have poor total quality of life compared to other children. The frequency of boys 
with adverse quality of life subscale scores was also high: physical (n = 26; 60.5%), 
psychosocial (n = 34; 79.1%), emotional (n = 30; 69.8%), social (n= 25; 58.1%) and 
school (n= 36; 83.7%). To our knowledge, there are no other reports of quality of life in 
KS children and very few on KS adults.  
 In 2009, de Ronde et al. measured quality of life in a sample of 46 KS men using 
the Rand-36 survey (de Ronde, et al., 2009).  Study findings showed that KS men scored 
10-20 points lower on all quality of life domain subscales compared to a healthy male 
reference population. All subjects in the de Ronde study were receiving testosterone 
replacement therapy with a mean treatment period of 12.6 years. The researchers 
concluded that irrespective of androgen therapy, quality of life was reduced overall. The 
investigators noted that KS patients in their study who had higher levels of education also 
had higher quality of life scores compared to KS patients who were less educated. De 
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Ronde et al. conjectured that more highly educated KS patients may be better equipped to 
handle the complex sequelae of KS and that patients with a less severe phenotype may be 
more highly educated (de Ronde, et al., 2009). 
While the measurement instrument and populations differed by age between the 
two studies, the current study showed a similar reduction in quality of life. 
In the current study, quality of life scores were reduced by 15% compared to 
healthy children (Varni, et al., 2007; Varni, et al., 2001). Varni et al. measured quality of 
life in a sample of over 2500 pediatric patients grouped according to 10 chronic disease 
clusters (Varni, et al., 2007). Compared to children with such devastating diseases such 
as diabetes, gastrointestinal conditions, cardiac disease, asthma, obesity, end stage renal 
disease, psychiatric disorders, cancer and rheumatic disease, KS boys in our study 
exhibited poorer scores in all quality of life domains (physical, psychosocial, emotional, 
social and school) except for children with cerebral palsy. 
Self-Concept 
 About one quarter of the KS boys showed an abnormally low total score for self-
concept which included subscale domain scores for behavioral adjustment, intellectual 
and school problems, physical attributes, freedom from anxiety, popularity and 
happiness. Although no prior research has examined self-concept of boys with KS, 
researchers have studied self-concept of children with other genetic conditions.  In a 1986 
study of girls with Turner Syndrome (TS), McCauley et al. reported that participants 
demonstrated significantly lower total self-concept T scores (p = < 0.001) compared to 
controls diagnosed with short stature (McCauley, et al., 1986). Differences between 
groups were also observed for self-concept subscales: intellectual and school status (p = 
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<0.01), physical appearance (p = <0.001), anxiety (p = <0.05), popularity (p = <0.001) 
and happiness (p = <0.01).  The results of McCauley et al. study support the findings 
reported here that children with genetic-related syndromes demonstrate low self-concept. 
 
Self-Esteem 
  Self-esteem was reduced in almost 40% of the sample in the current study and 
significant school-related learning problems were common. While over 90% of the boys 
in the sample were in grade level for age, over half (55.8%) of them were supported in 
the regular classroom with individualized education plans; evidence that special learning 
accommodations were being made for the boys.  Additionally, 16% of the boys in the 
current sample were being educated in special education programs to address learning 
disabilities. For boys with KS, early educational experiences with persistent learning 
struggles may create negative attitudes about themselves (Samango-Sprouse, 2001). In 
this study, scores for the quality of life school subscale showed that older boys have 
increased struggles with school issues (n= 25; 92.6%) compared to younger boys (n=11; 
68.8%). Collectively, these data are consistent with findings from earlier studies that 
learning problems are common and may get worse as boys mature.  
No other studies of self-esteem in boys with KS were identified. In a study with 
23 learning disabled seventh graders, Rosenberg and Gaier (1977) observed that children 
with learning disabilities had lower mean self-esteem scores compared to the non-
learning disabled group (Rosenberg & Gaier, 1977).  The overall percentage of KS boys 
with low self-esteem was observed to be higher compared to the learning disabled sample 
in the Rosenberg & Gaier study. The implications of low self-esteem include persistent 
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feelings of devaluation, and unworthiness that may persist into adulthood negatively 
affecting interpersonal relationships, employment and maladaptive behaviors for coping 
such as substance abuse (Bender, et al., 1995; Geschwind, et al., 2000). 
Mention should be made concerning the differences between overall scores for 
self-esteem and self-concept. While, on average, boys in this sample showed poor self 
esteem and self-concept within the normal range, the difference in these constructs must 
be acknowledged. Self-esteem generally refers to a person’s positive or negative attitude 
about self and their own feelings about perceived personal worth (Coopersmith, 2002), 
while self-concept involves a person’s self-perceptions in relation to the important 
aspects formed through the interactions of their environment (Piers, 1984). While we 
might expect that self esteem and self-concept scores would be concordant, this may not 
be a realistic expectation. Over a third of the sample of boys in this study showed low 
self-esteem scores while a quarter of them showed low self-concept. Since self-concept 
involves self-perceptions in relation to important aspects of their life, self-concept scores 
may have reflected a degree of coping or adaptation to their environment, thus showing 




Sixteen percent of our sample met the criteria for depression based in the 
Children’s Depression Inventory. There are currently no studies examining depression in 
children with KS. A 2007 paper by Boks et al. measured psychiatric morbidity in a Dutch 
sample of 31 men with KS between the ages of 24 and 63 years. (Boks, et al., 2007). 
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These investigators collected psychiatric diagnosis information from KS men who were 
receiving treatment at one major medical center in the Netherlands. Over half of the men 
in their sample (61%) had at least 1 psychiatric diagnosis, the most common of which 
was depression (19.4%). Other psychiatric diagnoses included panic disorder (9.6%), and 
bipolar disorder (6.4%). Less frequent diagnoses included auditory hallucination, visual 
hallucination, eating disorder, and paranoid delusions. This study was conducted with an 
adult sample who were all receiving psychiatric care at the same institution.  The sample 
size was small and was subject to ascertainment bias since they were selected from a 
population of patients receiving psychiatric care.  
In 1995, Bender et al. assessed the rate of psychiatric disorders in a sample of 39 
adolescents diagnosed with sex chromosome aneuploidy. Their sample included 
adolescents with 47 XXY, 47 XXX, 45 X and partial X monosomy. Thirteen of the boys 
in this study had KS and were found to have depression (23.1%) conduct disorder 
(15.3%) and substance abuse (15.3%). Of note, over half (53.8%) had more than 1 
psychiatric diagnosis. While the KS sample was small in this study, it came from an 
unselected sample of boys identified through genetic screening of 40,000 consecutive 
Denver newborns; all boys were screened with valid and reliable standardized 
psychological screening tools. Using a very different approach, the prevalence of 
depression in our sample of KS boys is similar to that reported by Boks and the Bender 
study. Taken together, these findings suggest that a greater understanding of psychosocial 




Hypothesis 1.1: KS-related physical phenotype as measured by the Klinefelter 
Syndrome Physical Phenotype (KSPHE) Score is inversely associated with scores for 
quality of life, self-concept, self-esteem and positively associated with depression. 
 
This hypothesis was partially supported. A greater number of KS physical 
features as measured by the KSPHE Score was associated with poorer quality of life total 
scores (ß = -4.02; p = 0.0015), and subscale scores for physical (ß = -4.49; p = 0.0013) 
and school quality of life (ß = -4.85; p = 0.0020). No relationships were observed 
between KSPHE score and those for self-concept, self-esteem or depression.  
Although this is the first study of KS children, other studies linking physical 
features associated with obesity and quality of life have shown similar relationships. 
Schwimmer et al. (2003) in a sample of 106 obese children (n = 57 males) between the 
ages of 5 and 18 years found that obese children had mean quality of life scores more 
than 20 points below those of healthy adolescents and that obese children had similar 
quality of life scores as children with cancer. Schwimmer et al. postulated that obese 
children and adolescents are at risk for social adjustment problems possibly owing to 
lowered self-expectations due to social, athletic and appearance issues (Schwimmer, et 
al., 2003).   
Varni et al. (2007) in a comparison of children with 10 chronic disease clusters 
found that obese children scored generally 10 points lower on the quality of life scales 
compared to healthy adolescents (Varni, et al., 2007).  In a sample of girls with TS, 
McCauley et al. (1986) found that short stature alone in TS girls was not the reason for 
social and emotional difficulties in TS girls, but that other phenotype anomalies such as 
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webbed neck and digital nail defects may be associated with lower self-concept. 
Supporting this reasoning, girls with a greater number of TS-related physical anomalies 
had lower scores on the physical attribute (r = -0.45; p =<0.05) and anxiety (r = - 0.52; p 
= <0.05) subscales. The McCauley study was limited by its a very small sample size (n = 
16) and lack of description regarding which TS-related physical anomalies were included 
in their correlation analysis. This study, however, was one of the first to examine the 
relationship between phenotype characteristics and negative psychosocial impact on 
children.  
Our current study failed to detect a significant relationship between KS-related 
physical features and self-concept.  This may be due to gender differences between the 
TS and KS populations.  Girls may be more sensitive to physical appearance than boys. 
Another explanation for the difference may be related to the variability observed in the 
KS phenotype. In our sample, the number of KS-related physical traits ranged from 0-10 
traits with a mean of 5.  Many of the physical traits associated with KS are not readily 
observable in a non-clinical setting. Tall stature, one of the KS traits, is generally not 
considered a negative characteristic in a boy. TS girls, however, may be noticeably 
shorter with visibly abnormal features such as webbed neck, and this may contribute to a 
more negative body image that results in lower self-esteem. 
 
Hypothesis 1.2: Testosterone level is positively associated with scores for quality of 




The findings did not support a relationship between serum testosterone (ng/dL) 
and psychosocial health. However, when serum testosterone level was dichotomized to 
normal versus low testosterone, (including values in the low-normal range for Tanner 
stage), low testosterone was an independent predictor of the interpersonal problem 
subscale of the CDI (ß = 10.6; p = 0.003) controlling for age. Hypothesis 1.2 was 
therefore, partially supported. 
 
Hypothesis 1.3  Physical phenotype as measured by the Klinefelter Syndrome 
Phenotype Index (KSPHE) is inversely related to testosterone. 
 
Hypothesis 1.3 was not supported. The positive association between serum 
testosterone and KSPHE was an unexpected finding. The original hypothesis postulated 
that reduced testosterone contribute to increased numbers of phenotype traits. Since the 
production of testosterone is related to sexual maturity and age, we originally conjectured 
that lower testosterone would be less associated with normal masculinization of body 
type and sexual development. The multivariate analysis showed that while controlling for 
age, number of KS traits increased by .003 points (ß = 0.00293; p = 0.0332) with each 
unit increase in serum testosterone (ng/dL). Since the KSPHE score is composed in part, 
of anthropometric measures related to growth and development, the positive direction of 
the relationship in KSPHE score may be explained by the effect of testosterone on 




Hypothesis 1.4 Testosterone levels are negatively associated with total cholesterol 
and insulin resistance as measured by the Homeostasis Model Assessment. 
 
Serum testosterone showed a positive association between BMI score and a 
negative association with HDL; each of which is observed in normal adolescent 
development in the absence of a KS diagnosis. Controlling for age in a multivariate 
model, we observed no relationship between BMI and serum testosterone. In another 
multivariate model, age but not testosterone was a predictor for HDL. Using low 
testosterone as a dichotomous variable, there was no relationship between 
cardiometabolic variables and low testosterone. Hypothesis 1.4 was, therefore, not 
supported. 
In summary, physical phenotype appears to be a contributing factor to poor 
quality of life, but serum testosterone was not. While phenotype did not predict self-
concept, self-esteem or depression, a significant portion of the children in the study 
attained poor scores on these psychosocial health assessment measures. Further study is 
needed to identify root causes and other contributing factors to poor psychosocial health 
in KS children. Additional investigation is recommended to study associations among 
physical health and hormonal influences on behavior, learning and social interaction. 
Further study is also recommended that may lead to individual or school-based 
interventions that would improve the psychosocial health overall for boys with KS. 
 
Aim II. To describe body composition and bone mineral density in a sample of 




Hypothesis 2.1 Boys with Klinefelter Syndrome have higher percent body fat as 
measured by DEXA compared to boys from a normative reference standard. 
 
In our retrospective sample, 4 out of 5 boys over 16 years of age had AP Spine 
BMD Z scores at -1.9 or  < -2.0. One boy who was overweight in comparison to the 
others in the over-16 age category showed AP Spine Z score of +1.4. Body fat as 
measured by DEXA for this group showed an overall mean % body fat at 29.35 ± 12.5. 
Normative standards for body fat by DEXA in children have shown that in healthy male 
children between the ages of 5-18 years, mean % body fat by DEXA was approximately 
19% (Shaw, Crabtree, Kibirige, & Fordham, 2007).  By that standard, the body 
composition assessed by DEXA of our sample showed 10% higher body fat compared to 
healthy male children. Aksglaede et al. (2008) measured body composition and bone 
mineral density in a sample of 24 KS boys between the ages of 4-18 years using DEXA 
scanning.  The researchers reported that lean body mass and bone mineral density were 
within normal limits while body fat mass was significantly higher compared to normal 
age-matched boys. These findings from this exploratory chart review are consistent with 
the body composition conclusions of Aksglaede et al.(2008) that early in childhood, there 
is a higher body fat mass compared to healthy children. Hypothesis 2.1 was supported. 
 
 
Bone Mineral Density and Body Fat 
 Childhood and adolescence is a developmental period when bone mass increases 
significantly and longitudinal growth accelerates (Gordon, et al., 2004). The amount of 
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bone gained during adolescence is thought to be a main contributor to peak bone mass in 
adulthood and is the major determinant of osteoporosis and fracture risk in older adults 
(Loro, et al., 2000).  
  
Hypothesis 2.2 Boys with Klinefelter Syndrome have lower bone mineral density as 
measured by DEXA compared to boys from a normative reference standard. 
  
In our sample of 20 KS boys, all of the boys except for 1 had TBBMD and AP 
Spine BMD that fell within 2 SD of normal. Four of the 20 boys, however, had AP spine 
Z scores between -1.6 and -2.2. While these observations are within the normal reference 
range for age and ethnicity, scores approaching the -2.0 Z score cutoff might suggest that 
early bone loss may be occurring in some boys.  With the majority of boys having BMD 
within the range of normal, hypothesis 2.2 is not supported. These findings are in 
agreement with others who also observed that BMD was normal in KS boys (Aksglaede, 
et al., 2008; Girardin, et al., 2009).  In adult KS patients, there is an increased of 
developing osteoporosis, osteopenia and bone fracture (Bojesen, Juul, et al., 2006).  The 
timing of bone loss, however, is not well documented. It has been reported that 25-48% 
of men with KS show decreased bone mass (Breuil & Euller-Ziegler, 2001) and that 
approximately 6-15% are diagnosed with osteoporosis ((van den Bergh, et al., 2001). 
While young children with KS have been shown to have normal bone mass, (Aksglaede, 
et al., 2008; Close, Fennoy, Smaldone, & Reame, 2010), no studies to date have provided 
evidence of whether bone loss begins in late adolescence or early adulthood. The 
observations from this study suggest that further research needs to be done on BMD in 
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young KS men beginning in late adolescence into the second decade of life to better 
characterize the timing of bone loss. 
 
Relationship between BMD and Age 
We further examined BMD and its relationship to age and body fat in this sample. 
We found a negative association between BMD and age for AP Spine Z score (ß =  - 
0.13; p = 0.0466) and TBBMD Z score (ß = -0.18; p = 0.0119). These findings suggest 
that, as KS boys become older, BMD decreases. Controlling for body fat, in multivariate 
analyses, AP Spine Z score (ß = -0.11; p =0.0287) and TBBMD Z scores (ß = -0.16; p 
=0.0030) continued to demonstrate a negative association with age. A weakness in the 
interpretation of these findings must be acknowledged since the BMD Z score controls 
for ethnicity and sex and not for the potential confound of tall stature frequently observed 
in boys with KS. Us of a healthy reference group may, therefore, be a poor comparison 
group. Future study should include case-matched controls. Given that childhood and 
adolescence is a time for establishment of peak bone mass in adulthood, bone health of 
KS boys is of clinical concern in the KS pediatric population. Bone health surveillance 
for KS boys during adolescence is therefore recommended for baseline assessment and to 
allow time for consideration of bone preservation interventions such as increased 
physical exercise and possibly the use of bone preservation medical therapies such as 
supplemental calcium, vitamin D and/ or the use of bisphosphonates. Currently 





Relationship between Bone Mineral Density and Body Fat 
 Throughout the life course, bone mass undergoes constant remodeling, a process 
regulated by a number of hormones including osteocalcin, insulin and fat-derived leptin 
and adiponectin (Confavreux, Levine, & Karsenty, 2009; Lee & Karsenty, 2008a). 
Previous literature suggests that increased fat mass may provide protection against 
osteoporosis (Albala, et al., 1996; Reid, Plank, & Evans, 1992). Our study found that 
body fat was a significant predictor of AP Spine Z scores (ß = 0.05; p = 0.0022) and 
TBBMD Z scores (ß = 0.06; p = 0.0016).  These findings were consistent with those of 
others who found similar relationships in children and adults (Albala, et al., 1996; Clark, 
Ness, & Tobias, 2006; Reid, et al., 1992).  
The literature, however, provides contrasting evidence on the relationship of body 
fat to bone. Gilsanz and colleagues, in a sample of 100 young women between the ages of 
15 and 25 years using computed tomography (CT), showed that increased subcutaneous 
fat predicted increased BMD, but that increased visceral fat predicted low bone mineral 
density (Gilsanz, et al., 2009). In a sample of adolescent females between the ages of 12 
and 18 years, Russell et al. (2010) also found that there was in inverse relationship 
between visceral fat and BMD (Russell, et al., 2010).  
In contrast using a sample of 300 healthy male and female adolescents, Agnieszka 
and colleagues (2007), in a sample of 300 healthy adolescent males and females, found 
that after controlling for lean body mass and trunk height/leg length, fat mass had a 
negative or no correlation with bone (Agnieska, et al., 2007). In 2010, El Hage et al. 
conducted a study with 65 healthy girls stratified by healthy weight, overweight and 
obese. Their results demonstrated that the obese girls showed increased BMD, but that 
  136 
 
the effect disappeared after controlling for lean body mass (El Hage, Moussa, & Jacob, 
2010).  
These contrasting findings may be attributable to differing characteristics of study 
cohorts (age, gender and period of sexual development) or also due to differences in 
measurement techniques such as DEXA (Agnieska, et al., 2007; El Hage, et al., 2010; 
Russell, et al., 2010) and CT (Gilsanz, et al., 2009) The interpretation of results from the 
current study, must therefore, be made with caution Given the small sample size and is 
therefore limited. 
  
Relationship between Testosterone and Bone Mineral Density 
 Testosterone is an important regulator of bone metabolism by its direct action on 
osteoblasts via androgen receptors and by aromatization to estrogens (Jackson, et al., 
1987). A critical stage of bone formation occurs during adolescence, so testosterone 
deficiency may contribute to increasing risk for future osteoporosis (Ferlin, et al., 2010). 
Findings of this study did not reveal an association between serum testosterone and AP 
Spine Z score or TBBMD score. It may be that due to the small sample of our 
retrospective chart review, our study was underpowered to detect this relationship. Since 
there are few randomized trials of osteoporosis therapies in men, there is uncertainty 
about when to screen for bone loss and what therapies might help preserve bone 
(Kaufman & Goemaere, 2008). General recommendations for good bone health include a 
healthy diet, exercise, modest sun exposure and avoidance of excessive alcohol use and 
smoking (Ferlin, et al., 2010). While there is evidence that testosterone replacement 
therapy is beneficial for improving bone mass in hypogonadal non-KS men (Snyder, et 
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al., 1999), there are no clinical trials that show evidence for this in KS men. Since there is 
no data on timing or dose of testosterone replacement and its specific action on bone, 
goals of testosterone substitution therapy aim for achieving mid-physiological range for 
young adults (Ferlin, et al., 2010). Since many KS adolescents do not show frank 
androgen deficiency and there is limited evidence for the documentation of bone loss in 
this general age group, testosterone therapy may not yet be considered a first-line therapy 
for bone preservation. In adult men with bone loss and normal testosterone levels, other 
bone preservation therapies may be beneficial such as the use of bisphosphonates 




The Biopsychosocial Model of Health Compromise in KS 
  The primary domains of the Biopsychosocial Model of Health Compromise in KS 
were explored in this study. Physical health and KS-related traits, reproductive hormones, 
cardiometabolic risk measures and psychosocial health characteristics  
were used to describe children with KS. Relationships between these measures were 
explored through the first aim of this study. The second aim of the study was explored 
within the biogenetic domain of the model, examining the relationships between bone 
mineral density, body fat and testosterone levels (Figure 5.1). The directional map of 
hypotheses is shown in Figure 5.2 indicating support of hypotheses by study findings. 
   For the first aim of the study an inverse association was observed between 
physical characteristics and quality of life, but not for self-concept, self-esteem or 
depression. Serum testosterone was positively associated with physical phenotype, but 
not with psychosocial measures or cardiometabolic measures. For the second aim of the 
study, KS boys were found to have higher percentage of body fat compared to healthy 
boys of similar age, with a few of the older boys showing low bone mineral density. For 
Aim II, we found an inverse association between age and BMD and a positive association 




































Figure 5.1 Study Findings Viewed Through the Biopsychosocial of Health Compromise 






















Conclusions and Recommendations 
In this study (Aim I), KS boys demonstrated a variable phenotype based on the 
number of observed physical traits as measured by an investigator-developed, cumulative 
index scale. On average, less than half of the full range of KS features reported in the 
literature was present in the majority of boys. 
This study uncovered a high proportion of boys with poor quality of life, and 
moderate rates of low self-concept and self-esteem. Depression was evident in a minority 
of the boys. Early psychosocial health screening is recommended to provide a baseline 
understanding of how the boys feel about themselves and their lives. Targeted 
interventions with personal or family counseling and in the school setting may help to 
ameliorate psychological and social issues. Quality of life overall may be improved if KS 
boys are evaluated for psychosocial vulnerabilities. 
A significant inverse association was seen between KS physical phenotype and 
quality of life, but no associations were seen with phenotype and self-concept, self-
esteem or depression. These associations need to be explored further to examine more 
specifically what features or patterns of features might contribute to reduced quality of 
life.  
Testosterone was positively associated with the physical phenotype and was an 
unexpected finding. We originally postulated that androgen deficiency might be 
responsible for some of the physical characteristics seen in KS. Most of the boys in the 
sample, however, showed a wide variation in phenotype and were not androgen deficient. 
The positive association between testosterone and phenotype may be related to the 
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growth and anthropometric measures that were used as phenotype criteria in the 
construction of the KSPHE. 
Peri-pubertal gonadotropin hormones showed evidence of early gonadal failure 
coupled with a low rate of androgen deficiency. These findings call into question the 
prophylactic use of testosterone in young children. Although beyond the scope of this 
study, the question remains whether testosterone therapy would be helpful in treating 
some KS-associated symptoms such as reduced upper body muscle mass, distribution of 
body fat, or gynecomastia and whether increasing serum testosterone might improve 
quality of life. 
Testosterone was not associated with any of the psychosocial health measures 
except for boys with low testosterone and increased interpersonal problem subscale of the 
CDI. Since the majority of boys in the sample were not androgen deficient, further 
exploration of psychosocial health is recommended to find explanations other than 
testosterone that might be responsible for psychosocial health vulnerabilities. 
Boys in this sample, including those who ere not overweight showed increased 
cardiometabolic risk factors. Cardiometabolic risks in children with KS need to be 
addressed in regular health maintenance visits. Monitoring of lipid is important for the 
purpose of recommending nutritional and exercise interventions in order to optimize 
cardiovascular health. For older boys who might have persistently high lipids despite diet 
and exercise interventions, statin therapy may be considered. As the body of evidence 
continues to emerge on the potential for adverse cardiovascular events in this young KS 
population, management guidelines seem warranted 
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While significant proportions of boys demonstrated cardiometabolic risk factors 
irrespective of weight category, no association was observed between testosterone and 
cardiometabolic biomarkers. With few boys showing androgen deficiency, testosterone 
does not appear to play a major role in the increase of cardiometabolic risk. 
Results of the retrospective chart review (Aim II) showed that KS boys have 
increased fat as measured by DEXA, and normal BMD.  BMD is inversely associated 
with age and positively associated with body fat.  No relationship was seen with T and 
BMD. Body composition and BMD screening need to be considered as a regular part of 
health maintenance for boys with KS. Early baseline values taken prior to puberty may 
enable clinicians to track bone health changes as KS boys develop through the pubertal 
stages. Our findings suggest that baseline and interval BMD screening with DEXA would 
be a good recommendation for the assessment of bone health in KS children.  
 
In summary, the findings of this study suggest that KS is a multidimensional 
congenital condition that adversely affects biological, psychological and social health. 
Since 75% of KS individuals are never diagnosed, new cost effective screening tools 
need to be created to identify those yet undiagnosed. Many boys diagnosed with learning 
disabilities, ADHD, autism spectrum disorder and behavioral problems may have 
underlying genetic diagnoses, such as KS, that might explain growth and development 
problems.  Early diagnosis of KS would be very helpful to clinicians and families in 
planning future health care for affected boys.  With early diagnosis, comprehensive 
assessment and targeted interventions such as customized medical care, educational 
planning, psychological counseling and rehabilitation services can be initiated.  
  144 
 
Much work needs to be done to understand and to reduce the social stigma 
associated with a condition of sex chromosome aneuploidy such as KS. Many families 
and KS individuals are reluctant to seek specialized care and services or to participate in 
research studies because of self-induced and perceived social stigma. One method of 
mitigating stigma is with the dissemination of knowledge to clinicians, researchers and to 
the lay public.  
Reducing future health risks for children with KS is very important. Knowing that 
children may be at risk for early cardiovascular disease, diabetes and osteoporosis later in 
life provides families and clinicians the opportunity to adjust lifestyle and to screen for 
signs of early signs of disease. 
A greater understanding of the interrelationships among the biologic and 
psychosocial aspects of KS would add greatly to the understanding of how children and 














 This study was the first to systematically assess features of the KS phenotype in 
relation to psychosocial health and reproductive hormone status during childhood. While 
the overall sample size was small, this is one of the largest cohorts of peripubertal boys 
with KS to be evaluated in such a way. The KS pediatric population is very difficult to 
recruit for research due to parental reluctance to allow participation. Reluctance to 
participate may be due to perceived stigmatization and fear of diagnosis disclosure within 
or beyond the family. The acquisition of 43 peri-pubertal boys with the understudied 
problem of KS in childhood is a strength of this study. The research questions and 
hypotheses were developed a priori for the cross-sectional study. The use of standardized 
psychosocial screening instruments and a single-laboratory for the blood assay analysis 






Because this study was cross-sectional and lacked a comparison group, findings 
are limited to association and causality may not be inferred. 
 
Measurement Issues & Possible Sources of Bias 
Questionnaires were self-report and were subject to social desirability bias.  In 
addition, self-report required recall of one month for the quality of life survey and two 
weeks for the depression survey. Developmental maturity may have presented bias in the 
recall of the items required for these surveys.   
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The primary investigator for this study also carried out unblinded data collection 
procedures for the anthropometric and clinical phenotype observations. While this was 
partially mitigated by having a second health care provider verify measurements, the 
potential for investigator bias must be acknowledged. Many of the clinical observations 
such as the presence of clinodactyly, gynecomastia, skeletal anomalies and hand tremor 
are subjective measures that may be vulnerable to investigator bias. 
The KSPHE Index was created as an exploratory approach to characterize 
phenotype in a quantifiable manner. It was created to collapse multiple physical features 
into a single index variable that described the cumulative KS phenotype.  This measure 
was guided by current research on KS and in consultation with pediatric endocrinologists 
at CUMC. This assessment tool will be tested in the future for reliability and validity. In 
its current form, the same score can be assigned to boys with very different sets of 
physical features, which may have differential relationships to other health parameters. 
 
Sample Issues 
 Sample size was limited. The study was subject to possible selection bias due to 
educational level of parents, the lack of diverse racial representation in the sample and 
the possibility that parents of more severely affected children might be more interested in 
study participation. The inclusion of boys who had received testosterone therapy at some 
point in their history was a major limitation of this exploratory study. To what extent the 
findings were influenced by postnatal treatment with this anabolic hormone is not known. 
However, in a preliminary analysis of the data, we explored this possibility and found no 
significant differences in boys when groups according to history of treatment, suggesting 
  147 
 
this was not a serious confound. Future studies should include randomized controlled 
trials to determine any true benefit of childhood therapies. 
 
Follow-Up Plans   
 
The cross-sectional study was a pilot study for a planned prospective follow-up 
study. Issues regarding subject recruitment, logistical matters of carrying out the study in 
multiple settings, adding a sibling cohort as a comparison group and budgetary planning 
will inform the future study. Findings of this study will be used as preliminary data for 
the planning and execution of grant applications to fund future studies.  
 
Areas for Future Research 
Future research will include the testing of reliability and validity of the KSPHE 
Index in other KS populations with multiple assessors blinded to the diagnosis. 
Additional research may also include further development of the KSPHE Scale to include 
psychosocial and neurocognitive indices and a weighting formula for each criterion for 
the tool.  Planning of a randomized control study to study the effect of hormone 
replacement during puberty on physical and psychosocial health is in progress.   
Qualitative studies are also needed to better define the child and adolescent experience of 
living with KS, how parents decide to disclose the KS diagnosis to their sons and how 
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E.  Table of Cronbach Alphas for Psychosocial Instruments: KS Sample    
 








Quality of Life Peds QL 4.0 
 
23 .91 0.89 
 
 Self-Esteem  Coopersmith Self-Esteem 
Inventory 
25 .80 -.86 0.84 
Self-Concept Piers-Harris2  
Short Form 
60 .71 -.94 0.92 
Depression Children’s Depression 
Inventory (CDI) 




















Appendix F  
Normal Reproductive Reference Ranges for Males by Esoterix Labs, Calabasas, Ca 2010 
 
Normal Ranges for Testosterone by Tanner Stage (TS) 
          TS 1= <3-10 (ng/dL) 
          TS 2= 18-50 
          TS 3 =100-320 
          TS 4 =200-620 
          TS 5 =350-970 
 
Normal Ranges for Free Testosterone by dialysis throughout puberty are unavailable 
 Adult Males 52-280 (pg/mL) 
% Free Testosterone 
             Adult males 1.5-3.2 
 
Normal Ranges for Follicle Simulating Hormone (FSH) by TS 
           TS 1= 0.26-3.0 (mIU/mL) 
           TS 2= 1.8-3.2 
           TS 3 =1.2-5.8 
           TS4 = 2.0-9.2 
           TS 5 = 2.6-11.0   
 
Normal Ranges for Luteinizing Hormone (LH) by TS 
           TS 1 = 0.02-0.3 (mIU/mL) 
            TS 2 = 0.2-4.9 
            TS 3 = 0.2-5.0 
            TS 4-5 = 0.4-7.0 
 
Normal Range for Estradiol  (E2) by TS              
            TS 1 = 5.0-11 (pg/dL) 
            TS 2 = 5.0-16 
            TS 3 = 5.0-25 
            TS 4-5 = 10-36       
 
Normal Ranges for Sex Hormone Binding Globulin (SHBG)             
Ages 1-8 years: 72-220 (nmol/L) 
            Pubertal Ages:  20-60 
 
Normal Ranges for Dehydroepianrosterone Sulfate (DHEAS) 
               TS 1 = 13y (ug/dL) 
               TS 2 = 42-109 
               TS 3 = 48-200 
               TS 4 = 102-385 




Appendix G Normal Values for Cardiometabolic Biomarkers 
 
*Recommended (desirable ranges) by Labcorp, Inc 2009 
**Cutoff recommended by Keskin et al. (Keskin, Kurtoglu, Kendirci, Atabek, & Yazici, 
2005) 
 
*Total Cholesterol (mg/dL) 
             <169 (desirable) 
*HDL (mg/dL) 
               >45 (desirable) 
*LDL (mg/dL) 
               <99 (desirable) 
*Triglycerides (mg/dL) 
               <110 (desirable) 
*Glucose (mg/dL) 
              ≤100 (desirable) 
*Insulin uU/mL * 
                8-13 y   <13 (desirable) 
                 >13 y   <17 (desirable) 
 
*Ages 8-13 years desirable insulin cut-off is <13 mg/dL. Ages > 13 years desirable 
insulin cut-off is < 17 mg/dL.  
 
*HgA1c 
                ≤5.6 (desirable) 
**HOMA 
               ≤ 3.16 (desirable) 






























































Quality of Life Scores in KS boys by Pubertal Group 
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